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Toxaphene production, in quantities similar to those of polychlorinated biphenyls, has resulted in
high toxaphene levels in fish from the Great Lakes and in Arctic marine mammals (up to 10 and
16 pg g-1 lipid). Because of the large variabiliity in total toxaphene data, few reliable conclusions
can be drawn about trends or geographic differences in toxaphene concentrations. New
developments in mass spectrometric detection using either negative chemical ionization or
electron impact modes as well as in multidimensional gas chromatography recently have led
researchers to suggest congener-specific approaches. Recently, several nomenclature systems
have been developed for toxaphene compounds. Although all systems have specific advantages
and limitations, it is suggested that an international body such as the International Union of Pure
and Applied Chemistry make an attempt to obtain uniformity in the literature. Toxicologic
information on individual chlorobornanes is scarce, but some reports have recently appeared.
Neurotoxic effects of toxaphene exposure such as those on behavior and learning have been
reported. Technical toxaphene and some individual congeners were found to be weakly estrogenic
in in vitro test systems; no evidence for endocrine effects in vivo has been reported. In vitro
studies show technical toxaphene and toxaphene congeners to be mutagenic. However, in vivo
studies have not shown genotoxicity; therefore, a nongenotoxic mechanism is proposed.
Nevertheless, toxaphene is believed to present a potential carcinogenic risk to humans. Until now,
only Germany has established a legal tolerance level for toxaphene-0.1 mg kg-1 wet weight for
fish. - Environ Health Perspect 107(Suppl 1 ):115-144 (1999). http.//ehpnet1.niehs.nih.gov/
docs/1999/Suppl-1/1 15-144deGeus/abstract.html
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Toxaphene, a complex mixture of polychlo-
rinated camphenes, was first introduced in
1945 by Hercules Co. (Wilmington, DE)
as Hercules 3965. Until the mid 1980s, it
was mass produced and widely used as an
insecticide, particularly in the cotton-grow-
ing industry. It was also used as a piscicide
to control rough fish (undesired stock) in
various water systems (1). The lipophilic,
persistent, and volatile natures of toxa-
phene have contributed to its global disper-
sion throughout freshwater and marine
environments. Traces of toxaphene have
even been found in remote areas such as
the Arctic (2) where the pesticide was
never used. In addition to bioaccumulating
in biota inhabiting these regions, toxa-
phene also has been detected in humans
(3-10). Toxaphene was banned by the
U.S. Environmental Protection Agency
(U.S. EPA) in 1982, an example that was
followed by many countries. However, in
the early 1990s toxaphene detected in
marine fish in Europe caused concern
about the relationship of human health
and fish consumption. Therefore, increased
attention has been focused on toxaphene,
both in the analytic and toxicologic fields.
Research in this field has received further
impetus with the synthesis of individual
compounds of toxaphene and their increas-
ing commercial availability (11,12). Using
individual standards, we can gain more
insight into the transport, fate, and toxico-
logical effects of toxaphene in the environ-
ment. Although identification of individual
congeners provides more detailed informa-
tion, it also leads to more complicated
analyses. Another problem lies in the
nomenclature of individual compounds.
Proposals have been published recently for
codes simpler than the systematic nomen-
clature now in use. These proposals will be
discussed in this review.
In 1997 a European research project
titled "Investigation into the Monitoring,
Analysis and Toxicity of Toxaphene"
(MATT) was initiated. As part of the pro-
ject, an update of available knowledge on
the developments in toxaphene analysis,
new environmental data, and toxicology
was prepared. To avoid duplication of the
extensive review on toxaphene published by
Saleh in 1991 (1), this review concentrates
on developments since 1990.
Physical and Chemical
Properties
Toxaphene (CAS No. 8001-35-2) was one
of the main products produced by the
Hercules Co. in the United States (1). The
process of producing toxaphene consists of
extracting crude ax-pinene from pine
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stumnps, using methylisobutylketone, heat,
and pressure. Isomerization of the U(-pinene
produces camphene, bornylene, and
uo-terpineol. The camphene is then subse-
quently chlorinated under ultraviolet (UV)
light to produce toxaphene. The average
chlorine content is 67 to 69% (13). Struc-
tures of the main components of toxaphene
are shown in Figure 1.
Toxaphene is a yellow, waxy solid and
has a mild terpene odor, with softening
occurring at a temperature range of 343 to
363K. Although readily soluble in most
organic solvents, it is more soluble in aro-
matic than aliphatic hydrocarbons. Its aver-
age elemental composition is C1oH1oC18
(1). 1Toxaphene comprises at least 180 to
190 comnponents, most with the formula
Cl(H18-nCln or C10H16-,Cln, where n is 6
to 10 (14). Buser et al. (15) report that
polychlorobornanes (C10H18 nCL, n=
5-12) are formed as the main components
in a Wagner-Meerwin-type rearrangement
reaction. The peak area percentage of all
components identified, measured using the
electron capture detector (ECD), amounts
to 50% of the total toxaphene area (1).
The commercial product is relatively
stable but may be degraded by losing HCI
or Cl2 with prolonged exposure to sun-
light, alkali, or temperatures above 393K
(16). Saleh (1) found that technical
toxaphene does not undergo a serious
change wvhen exposed to normal sunlight.
Saleh and Casida (17) and Parlar et al.
( 18) reported that irradiation at wave-
lengths below 290 nm results in reductive
dechlorination and dehydrochlorination;
radiation above 290 nm does not appear to
affect toxaphene composition. When
adsorbed on silica, however, technical
toxaphene is completely mineralized to
C02 and HCl at 230 nm (19).
A specific gravity of 1.6 kg liter-1 has
been reported for technical toxaphene
(20). Vapor pressure and the log octanol-
water partition coefficient (Ko,,) value have
been estinmated to be comparable to that of
hexachlorobenzene (HCB), 1.73 x 10-3 Pa
at 298K (21), and a log KO,,, of 5.5 (22).
Howard (23) and Sullivan and Armstrong
(24) recorded KOU, values of 4.82 to 6.4,
respectively. A log Kol0, value of 6.44 was
recorded by Hooper et al. (25). This is
somewhat lower than that of technical
polychlorinated biphenyl (PCB) mixtures
but higher than those ofp,p'-DDT and its
metabolites, suggesting that the biocon-
centration of toxaphene is high. These
data are diffictult to compare because of the
variety of mixtures used. Bioconcentration
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Figure 1. Carbon skeletons of (A) bornane, (B) bornene, (C) bornadiene, (D) camphene, and (E) dihydrocamphene
The numbering of skeletons Dand Eis as proposed by Hainzl (63).
factors (BCFs) of 2 x 106 have been
observed by Kucklick et al. (26) for
toxaphene in Arctic cod. This value is
higher than that predicted from the log
KOW' On the basis of their vapor pressure
calculations, Wania and Mackay (27) sug-
gested that toxaphene changes its chemical
characteristic from gas phase to largely
aerosol absorbed within the range of global
environmental temperatures. At 298K, less
than 10% is adsorbed to aerosols; at 253K,
almost 90% is adsorbed. This implies that
with a change in temperature, most
toxaphene in the air condenses onto parti-
cles present in the atmosphere and thus
becomes subject to wet and dry deposi-
tion. Toxaphene is transferred more
rapidly from the atmosphere to soil and
water at low temperatures.
Water solubility values of toxaphene
have been reported with an equally broad
spectrum and range from 0.4 mg liter-1 at
298K (28) to 0.55 to 3.3 mg kg-1 at 293
to 298K (24).
The most important factor determining
the flux between the air-water interface is
the Henry's law constant (H). Murphy et al.
(29) measured H for a technical mixture of
toxaphene congeners as 0.62 Pa m3 mole-1
at 293K. Using fugacity-based equations
(22,30), the direction and magnitude of
the flux can be calculated according to
McConnell et al. (31), who assumed that
the temperature slope determined by
Tateya et al. (32) for PCBs is also valid for
toxaphene. Using the H measurement, a
toxaphene-specific intercept can be deter-
mined and from that a temperature-
corrected H can be obtained. This value
allows the direction of the flux to be calcu-
lated. Such calculations suggest that up to
2 kg of material would be deposited in
Lake Baikal, Russia, per month by gas
exchange; the process is further enhanced
by the low water temperatures of the lake
(32). More accurate congener-specific H
values are required to improve these esti-
mates. This flux direction of air to water
has also been recorded by Bidleman et al.
(33). Hoff et al. (34) report that addi-
tional inputs via precipitation and particle
deposition are likely to be 10 to 20 times
less than those from gas absorption.
Most chlorinated bornanes contain at
least one chlorine atom at C2 and C1O,
whereas the bridging carbons, C1 and
C4, are nonchlorinated (35). Technical
toxaphene, as synthesized by photoinduc-
tion, has a high percentage of com-
ponents containing a dichloro group in
the C2 position (36).
Toxaphene congeners demonstrate
different stabilities under UV light, acid,
and alkaline treatment. Fingerling et al.
Environmental Health Perspectives * Vol 07, Supplement * February 999
TOXAPHENE: OCCURRENCE, ANALYSIS, AND TOXICOLOGY
(14,36) demonstrated that in soil 2,2,5-
endo,6-exo,8,9, 10-heptachlorobornane,
2,2,5-endo,6-exo,8,8,9, 1 0-octachloro-
bornane, 2,2,5-endo,6-exo,8,9,9,10-
octachlorobornane, 2,2,3-exo,5-endo,
6-exo,8,9,9, 10-nonachlorobornane, 2,2,5-
endo,6-exo,8,8,9, 10,10-nonachlorobornane,
and 2,2,5-endo,6-exo,8,9,9,10,10-nona-
chlorobornane (B[30012]-(1 11), B[30012]-
(211), B[30012]-(121), B[32012]-(121),
B[30012]-(212), and B[30012]-(122) [(37)
and as discussed in "Nomenclature"] were
all dechlorinated by reductive removal of
one chlorine atom from each geminal
dichloro group beginning with that in the
C2 position, which is the most labile
under anaerobic conditions. The authors
suggest that dechlorination also occurs
during photodegradation and that the
dechlorination rate is nonachlorobornanes >
octachlorobornane > heptachlorobornanes.
Fingerling et al. (14) also found that
during irradiation in solvents, the bornane
structure is generally preserved and pho-
toability seems to depend on the presence
of a geminal dichloro group in C2 posi-
tion. The dechlorination rate is enhanced
by an additional chlorine atom in the C3
position but not by a dichloro group in
C5 position. Components with only a sin-
gle chlorine atom at each secondary ring
atom in alternating orientation, for exam-
ple, 2-endo,3-exo,5-endo,6-exo,8,8,10,10-
octachlorobornane, 2- endo,3- exo, 5- endo,
6-exo,8,8,9,10,10-nonachlorobornane, or
2-endo,3-exo,5-endo,6-exo,8,9,9, 10,10-
nonachlorobornane (B[12012]-(202),
B[12012]-(212), or B[12012]-(212) [(37)
and as discussed in "Nomenclature"],
were found to be extremely photostable.
Sources
The Hercules Company first introduced
toxaphene as an insecticide in the late
1940s (1). In the ensuing years toxaphene
had a variety of uses until it was banned by
the U.S. EPA in 1982 because it was sus-
pected of being a human carcinogen and a
persistent hazardous compound to nontar-
get organisms. A stipulation existed that
stocks could be used through 1986, as
reported by Voldner and Smith (38) and
Rapaport and Eisenreich (39). By that year
usage had dropped from a reported
45x 106 kg year1 to 7.20 x 106 kg year-'.
Over 180 companies are reported to have
produced toxaphene since 1947 with vari-
ous product names (1) (Table 1).
In 1989 there were 168 registered uses
of toxaphene in the United States (40)
and more than 277 worldwide to control
Table 1. General aspects of the reviewed classes of compounds.
Class of compounds General formula Number of congeners
Chlorinated bornanes C10H1,xClx 32,767
Chlorinated bornenes C1oHlsxClx 8,191
Chlorinated bornadienes C10H1-14-Cx 2,047
Chlorinated camphenes C10H16,CIx 16,383
Chlorinated dihydrocamphenes C10H18xClx 65,534
167 major insect pests encountered in the
production of agricultural commodities
and crops. Its use in livestock dips as a
miticide and in lakes as a piscicide to con-
trol rough fish populations has been widely
reported (1). The interpolated total global
use between 1950 to 1993 was 1330 x 106
kg and from 1970 to 1993, 670 x 106 kg
(41). This estimation was based on data
from the literature and on contacts with
international agencies and researchers; data
quality varies and shows large spatial and
temporal gaps.
The United States (42), the Central
American states, and the former Soviet
states have recorded the highest usage of
toxaphene. This may be because more
detailed information on usage was received
from these countries, whereas in other
countries information often is not recorded
or is kept confidential (41). El-Sebae et al.
(28) report that toxaphene continues to be
used in African countries, especially
Ethiopia, Sudan, Tanzania, and Uganda
where field runoff eventually flows into the
Nile and ultimately into the Mediterranean
Sea. These runoffs could be a source of
future contamination. Information is lack-
ing for other African countries.
In 1970 toxaphene was used in a
formulation called polydophen, which was
composed of 20% DDT and 40% toxa-
phene in a diesel fuel oil solvent. This was
recommended as a substitute for DDT in
Central Asia (31). Bidleman et al. (43) and
Voldner and Schroeder (44) suggested that
toxaphene application likely continues in
the Soviet states, Mexico, Romania,
Hungary, Poland, and the Indian subconti-
nent as well as many African nations,
Nicaragua, and Mexico.
The most recent data available from the
Food and Agricultural Organization of the
United Nations (FAO) on toxaphene usage
[as reported by Swackhamer et al. (45)]
indicates that Korea and Mexico were the
only countries using toxaphene into the
1980s; Mexico reported using 600 tonnes
in 1985.
Although toxaphene is currently
banned in many countries, Argentina and
Mexico allow restricted use. Toxaphene
was used only in small quantities in Sweden
and has been banned since 1956 (46).
The Soviet government restricted the
use of toxaphene in 1971. It is thought to
still be in use as an insecticide for sugar
beets, peas, potatoes, mustard, rape seed,
and perennial herbs in the following for-
mulation: 50% active ingredient, 30% oil,
15% amalgamate at 1.6 to 3.0 kg ha-1
during sprout stage (47). Voldner and Li
(41) report that 1 x 108 kg of toxaphene
has been used since 1970 in the former
Soviet Union.
In 1956 toxaphene was recommended
for nationwide use in Egypt as an insecti-
cide to protect against cotton leafworm,
pink bollworm, and spiny bollworm in
cotton fields. Field efficacy was the only
consideration for the use. It was applied as
a formulated emulsifiable concentrate of
toxaphene (60% chlorinated camphene)
and used in four successive sprays during
the cotton season. This method of admin-
istering the chemical caused maximum
contamination of soil and can result in up
to 20% being released into air, 20 to 50%
into soil, and 20 to 50% into water sys-
tems. This can ultimately lead to air and
groundwater pollution and to soil contami-
nation. A concentration of 10 ppm has
been reported in Egyptian soil, biota, and
water (1). Although insecticide application
doubled between 1956 and 1961, major
crop losses were experienced as efficacy
decreased and insect resistance increased as
a result of removal of the insect's natural
enemies. Egypt alone used 54x 103 kg
toxaphene between 1956 and 1961, an
estimated 25% of the non-U.S. toxaphene
use (28). The resistance level of the cotton
leafworm was 26-fold that of the labora-
tory controls. This led to Egypt banning
toxaphene in 1961, not because of its envi-
ronmental impact but because of the poor
efficacy factor.
It was previously thought that chloro-
hydrocarbons were produced in the wood
pulp industry from residual monoterpenes
during the chlorobleaching process.
However, no evidence has been found of
compounds identical to the main congeners
in commercial toxaphene. This indicated
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that toxaphene in fish did not come from
chlorobleaching of pulp (48). However,
chlorinated camphenes are present in pulp
mill recipients (bleached Kraft pulp mill
discharged organic matter in lake sedi-
ment) (49). Chlorine bleaching of wood
pulp produces chlorinated compounds
similar in composition to toxaphene but
with lower chlorine content (50).
Rappe et al. (51) reported that the main
chlorobornanes Tox9, TC1, TC2, TC6,
and TC7, which are most likely 2-endo,3-
exo,5-endo,6-exo,8,8, 10,1 0-octachloro-
bornane, 2-endo,3-exo,5-endo,6-exo,8,9,
10-heptachlorobornane, an as yet unknown
heptachlorobornane, 2- exo,3- endo, 5- exo,
8,9,9,10,10-octachlorobornane, and 2- exo,
5,5,8,9,9,10, 10-octachlorobornane
(B[12012]-(212), B[120121-(111), ?,
B[21020]-(122), and B[20030]-(122),
respectively [(37); see discussion in "Nom-
enclature") (15,52), were detected in sam-
ples obtained close to pulp mills. These
chlorobornanes were probably present
because of aerial transport and/or degrada-
tion in the sediment. Additional chlorobor-
nanes (in particular, hexachloro congeners)
were observed in several of the samples that
were closer to the pulp mill (4 km as
opposed to 150 km).
Toxaphene Use in the
Great Likes ofNorth America
Much of the research on toxaphene has
been conducted in the Great Lakes of
North America, with conflicting data on
the sources of pollution. These range from
the use of toxaphene as a piscicide to the
contribution of the wood pulp industry
in addition to atmospheric sources.
Swackhamer et al. (53) report that approx-
imately 1% or less of U.S. toxaphene use
was in the Great Lakes basin (54). The
rate of use in the basin was approximately
1 x 106 kg year` between 1970 and 1977
and peaked around 1977. Thus, the pres-
ence of toxaphene in the Great Lakes has
been largely attributed to long-range
atmospheric transport from the southern
United States or from Central America fol-
lowed by wet and dry deposition to the
lakes (55,56).
Historical investigation of records on
Lake Michigan revealed that 224 x 103 kg
of toxaphene was used in the Green Bay
watershed between 1950 and 1980, with
most used as a pesticide on cropland but
small amounts on livestock and in lakes as
a piscicide. It has been noted that even if
there were only a 1% runoff into Lake
Michigan, this would represent a large
fraction of the estimated inventory of
toxaphene in the lake, i.e.,11 x 103 kg (57).
Inputs from the atmosphere to water
surfaces such as the Great Lakes include dry
fallout of particulate-associated contami-
nants, washout of gas phase and particulate
phase contaminants by precipitation events,
and gas transfer across the air-water inter-
face (58). Oehme et al. (10) reported that
the continual process of transport, deposi-
tion, revolatilization, and new transport
along a decreasing temperature system
results in accumulation of toxaphene in sed-
iments because vapor pressure becomes so
low that it restricts atmospheric transport.
In the 1960s several lakes in
Wisconsin were treated with toxaphene to
kill rough fish. Kidd et al. (9) reported
that concentrations of toxaphene in fish
in Laberge, Canada, were entirely due to
atmospheric input followed by long food
chain bioaccumulation giving rise to haz-
ardous concentrations in fish. Kidd et al.
(9) provide further information on possi-
ble sources and report that some conta-
mination of Lake Ontario was due to
surreptitious dumping.
Howdeshell and Hites (59) claim that
the Niagara River is the main riverine
source of sediment and water to Lake
Ontario and therefore likely to be a source
of some toxaphene in the lake; atmospheric
deposition is also important.
Scheel (60) reports that toxaphenelike
contaminants found in Michigan sport
lakes may not be completely due to the
presence of toxaphene compounds. It was
suggested that they may be due to a mix-
ture of chlorinated bicyclic monoterpenes,
including the chlorinated pinenes, occur-
ring as unwanted byproducts from chlori-
nation of naturally occurring plant-derived
product materials. Results suggest that not
all chlorinated bicyclic monoterpenes
found in fish tissue are the result of chlori-
nated camphenes or camphanes from
toxaphene but may be from other sources
such as the natural product family of
bicyclic monoterpenes including pinene
and borneol (61).
Nomenclature
For many years it was assumed that the
pesticide toxaphene consisted primarily of
chlorinated bornanes in addition to small
amounts of chlorinated bornenes and
even smaller amounts of chlorinated bor-
nadienes (62). The existence of bornenes
and bornadienes was based on data
obtained with gas chromatography (GC)
with negative chemical ionization mass
spectrometry (NCI/MS) studies. Mass
spectra with fragments 2 or 4 amu below
the [M-Cl]- ions of bornanes were inter-
preted as bornenes and bornadienes.
However, new insights into synthetic path-
ways of technical toxaphene indicate the
formation of camphenes and dihydrocam-
phenes (63). Therefore, the observed mass
spectra probably should be attributed
mainly to chlorinated camphenes and dihy-
drocamphenes. According to Saleh (62),
the technical mixture also consists of small
amounts of other chlorinated hydrocarbons
and nonchlorinated hydrocarbons.
As can be seen from Table 1, the total
number of theoretical congeners calculated
from the formula from Vetter (64) from all
five classes of compounds is extensive. At
present, 61 compounds of technical
toxaphene have been identified (65); these
chlorinated compounds consist of 48
bornanes, 6 bornenes, 1 bornadiene, 5 cam-
phenes, and 1 dihydrocamphene. Never-
theless, the number of congeners can easily
lead to confusion in systematic names and
nomenclatures, especially because many of
them are enantiomers.
On the basis of structural considera-
tions, Hainzl et al. (66), using an a-chiral
separation, calculated that 138 bornane
and 59 camphene congeners may be
found at significant concentrations.
Jansson and Wideqvist (67) reported the
separation of 670 individual components
in technical toxaphene. Zhu et al. (68)
recorded more than 300 penta- to deca-
chlorobornanes and bornene/camphene
isomers after collection of five fractions
from high performance liquid chromatog-
raphy (HPLC) on silica gel, whereas they
found only 76 partially resolved peaks
with possible coelution in a total ion chro-
matogram (150-500 amu) when the mix-
ture was not preseparated; CC-NCI/MS
detection was used in both instances. De
Boer et al. found 246 compound peaks in
technical toxaphene using two-dimensional
heart-cut GC-ECD, whereas they found
only 107 peaks using a single-column
GC-ECD setup (69).
Trade Names, Names of Classes
ofCompounds
Although toxaphene is the most commonly
used name, a wide variety of trade names
exists (Table 2) (65,70,71). Other names
used for toxaphene are compounds of tech-
nical toxaphene (CTTs) (71), polychlori-
nated monoterpenes (71), polychlorinated
camphenes (PCCs) (72), polychlorinated
terpenes (25), and chlorinated bornanes
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Table 2. Common names and trade names of toxaphene.a
Trade names Common names
Allotox Geniphene Synthetic 3956 Toxaphene
Attac Gy-phene Toxadust Camphechlor
Chem-Phene Hercules 3956 Toxadust 10 Chlorinated camphene
Chlor Chem T-590 Huileux Toxakil Octachlorocamphene
Chlorter Melipax Toxyphen Polychlorocamphene
Cristoxo-90 Morox Toxaspra
Dark Penphene Toxon 63
Delicia Fribal Phenacide Toxyphen
Estonox Phenatox Vapotone
Fasco Terpene Strobane-T
aCompiled from Coelhan et al (65), Sergeant and Onusaka (70), and Krock et al. (71).
(CHBs) (73), where several of these names
only contain one of the groups present in
the technical mixture.
The variety of trade and common
names used for toxaphene, in addition to
the trivial names of various compound
classes referred to in Table 1, complicate
any nomendature system. Names no longer
supported by International Union of Pure
and Applied Chemistry (IUPAC), such as
norbornanes and camphanes for bornanes
and iso-camphanes for dihydrocamphenes,
compound the naming problem.
Systematic Names
It is a complex task to formulate systematic
names for all groups of compounds men-
tioned above (Table 1) that conform to
IUPAC rules. The structure of these com-
pounds is given in Figure 1. The generally
accepted systematic nomenclature for bor-
nanes, according to IUPAC rules, is based
on the following rules and agreements
(Figure IA) (74,75):
* Numbering of the carbon atoms, as
shown in Figure IA (as presented by
IUPAC).
* Substituents on the six-membered ring
that point downward are in the endo
position and substituents that point
upward are in the exo position (the
bridging carbon, C7, is above the
ring).
* The carbon atom above the C2-C3
bond is C9, the carbon above the C5-
C6 bond is C8.
* The lowest possible numbering should
be applied. The carbon neighboring
Cl is decisive for the direction of num-
bering. If both carbons next to C1 bear
the same number of chlorine atoms,
substitution of the next carbon in the
ring is decisive in determining the
direction of numbering. If these are
also equivalent, the first carbon with an
endo chlorine determines the direction
of numbering.
* Enantiomers receive the same systematic
nomenclature.
For bornenes (Figure 1 B) and bornadi-
enes (Figure 1C) the following agreements
and additonal rules should be applied:
* If one double bond is present, the car-
bon atoms at this bond are numbered
C2 and C3.
* If two double bonds are present, the
numbering of the six-membered ring
should result in the lowest possible
numbers, as with the bornanes.
* As with the bornanes, the C9 carbon
should be positioned over the C2-C3
double bond.
The systematic names are even more
complicated for chlorinated camphenes
(Figure ID) and dihydrocamphenes (Figure
1E) than for the chlorinated bornanes,
bornenes, and bornadienes. Coelhan and
Parlar (75) suggest that the systematic
name for nonsubstituted camphene should
be 2,2-dimethyl-3-methylene-8,9, 1 0-tri-
norbornane and that other substituted cam-
phenes should be regarded as derivatives of
8,9,1 0-trinorbornane. However, according
to Vetter (76), IUPAC has abolished the
name norbornane, which was used to indi-
cate the bornane structure without C8, C9,
and CIO. In addition, considering chlori-
nated camphenes and dihydrocamphenes to
be chlorinated 8,9,10-trinorbornanes cre-
ates even longer systematic names. More-
over, such names would strongly depend on
the substituents present.
Systematic names for chlorinated
camphenes and dihydrocamphenes can
also be regarded to have bicyclo(2.2.1)
heptane as their basic structure (64,75).
The nonsubstituted bornane would then
become 1 .7.7-trimethyl-bicyclo(2.2. 1)
heptane. Camphene and dihydrocam-
phene would be referred to as 2,2-
dimethyl-3-methylene-bicyclo(2.2. 1)hepta
ne and 2,2,3-trimethyl-bicyclo(2.2.1) hep-
tane, respectively. Chlorinated camphenes
and dihydrocamphenes will receive very
long systematic names, which can easily
lead to confusion.
Hainzl (63) proposed systematic names
based on a fixed numbering of the
camphene skeleton (Figure 1D,E). This
approach is quite straightforward, resem-
bles the bornane nomenclature, and is
more user friendly. However, IUPAC does
not yet support assigning these fixed num-
bers and, in addition, there still are no
IUPAC rules for designating C8 and C9
orientations in camphene (76).
Nomencature Systems
Because chlorinated bornanes are the most
abundant compounds in technical toxa-
phene, most attention has been devoted to
them, both with regard to analytic method
development and monitoring, and nomen-
clature. In the past systematic nomencla-
ture of the bornane skeleton has been
nonuniform because several authors have
cited the IUPAC nomenclature incor-
rectly, particularly the C8 and C9 posi-
tions (Figure 1) (74). Difficulties in
formulating the correct systematic names
for chlorinated bornanes were solved when
IUPAC assigned definitive numbering for
the carbon skeleton.
Because of the extensive systematic
names for chlorinated bornanes (e.g., 2-
endo,3-exo,5-endo,6-exo,8,9,9, 10, 10-
nonachlorobornane), isolated congeners
were often designated by simpler names
such as T12, Toxicant A, Toxicant Ac,
Toxicant B, TOX8, and TOX9; however,
a clear nomenclature system was lacking.
Several authors proposed and used more
systematic nomenclatures in attempts to
remedy this situation. Table 3 gives an
overview of these nomenclatures, which
will be discussed below.
The nomenclature used by Burhenne
et al. (11) and Hainzl et al. (77) is based
on GC retention on a certain stationary
phase. Consisting simply of a 2-digit code
representing a peak in the technical
mixture, the nomenclature can be applied
to chlorinated bornanes, camphenes, and
dihydrocamphenes.
To indicate enantiomers, an additional
code, "+" or -, is proposed. However,
apart from the fact that the code does not
provide any structural information, one
also must consider that a) with such large
numbers of congeners, coelution cannot be
excluded (69); Parlar no. 42, for example,
represents at least two different chloro-
bornanes (77); b) the chlorinated bor-
nanes, camphenes, and dihydrocamphenes
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Table 3. Systematic names of compounds present in toxaphene and their codes of alternative nomenclatures presented in the literature.
Parlar Nikiforov Oehme and Andrews and Wester
nos. et al. Kallenborna Vetter et al.
Systematic name (11,77) (78) (79) (74) (37,80)
2-exo,3-endo,6-endo,8,9,1 0-hexachlorobornane
2-exo,3-endo,6-exo,8,9,1 0-hexachlorobornane
2,2,5,5,9,10,1 0-heptachlorobornane
2,2,5-endo,6-exo,8,9,1 0-heptachlorobornane
2,2,5-exo,8,9,1 0,1 0-heptachlorobornane
2-endo,3-exo,5-exo,6-exo,8,1 0,1 0-heptachlorobornane
2-endo,3-exo,6-exo,8,9,1 0,1 0-heptachlorobornane
2-exo,3-endo,5-exo,8,9,10,1 0-heptachlorobornane
2-exo,3-endo,5-exo,9,9,10,1 0-heptachlorobornane
2-exo,3-endo,6-endo,8,9,1 0,1 0-heptachlorobornane
2-endo,3-endo,5-exo,6-exo,9,1 0,1 0-heptachlorobornane
2-exo,3-exo,5-endo,8,9,1 0,1 0-heptachlorobornane
2-endo,3-exo,5-exo,6-exo,9,1 0,1 0-heptachlorobornane
2-exo,5,5,8,9,10,1 0-heptachlorobornane
2-exo,5,5,9,9,1 0,1 0-heptachlorobornane
2,2,3-exo,5-endo,6-exo,8,9,1 0-octachlorobornane
2,2,5,5,6-endo,8,9,1 0-octachlorobornane
2,2,5,5,8,9,1 0,1 0-octachlorobornane
2,2,5,5,9,9,1 0,1 0-octachlorobornane
2,2,5-endo,6-exo,8,8,9,1 0-octachlorobornane
2,2,5-endo,6-exo,8,9,9,1 0-octachlorobornane
2,2,5-endo,6-exo,8,9,1 0,1 0-octachlorobornane
2-endo,3,3,5-exo,6-exo,9,1 0,1 0-octachlorobornane
2-endo,3-endo,5-exo,6-exo,8,9,1 0,1 0-octachlorobornane
2-endo,3-exo,5-endo,6-exo,8,8,1 0,1 0-octachlorobornane
2-endo,3-exo,5-endo,6-exo,8,9,1 0,1 0-octachlorobornane
2-endo,3-exo,5-exo,6-exo,8,9,1 0,1 0-octachlorobornane
2-exo,3-endo,5-exo,8,9,9,1 0,1 0-octachlorobornane
2-exo,3-exo,5,5,8,8,1 0,1 0-octachlorobornane
2-exo,3-exo,5,5,8,9,1 0,1 0-octachlorobornane
2-exo,5,5,8,9,9,1 0,1 0-octachlorobornane
2,2,3-exo,5,5,9,9,1 0,1 0-nonachlorobornane
2,2,3-exo,5-endo,6-exo,8,9,9,91 0-nonachlorobornane
2,2,3-exo,5-endo,6-exo,8,9,1 0,1 0-nonachlorobornane
2,2,5,5,6-exo,8,9,9,1 0-nonachlorobornane
2,2,5,5,8,9,9,1 0,1 0-nonachlorobornane
2,2,5-endo,6-exo,8,8,9,10,1 0-nonachlorobornane
2,2,5-endo,6-exo,8,9,9,10,1 0-nonachlorobornane
2-endo,3,3,5-exo,6-exo,8,9,1 0,1 0-nonachlorobornane
2-endo,3-exo,5-endo,6-exo,8,8,9,1 0,1 0-nonachlorobornane
2-endo,3-exo,5-endo,6-exo,8,9,9,1 0,1 0-nonachlorobornane
2-exo,3-endo,5-exo,6-exo,8,8,9,1 0,1 0-nonachlorobornane
2,2,3-exo,5,5,8,9,9,1 0,1 0-decachlorobornane
2,2,3-exo,5-endo,6-exo,8,9,9,10,1 0-decachlorobornane
2,2,5,5,6-exo,8,9,9,1 0,1 0-decachlorobornane
2-endo,3,3,5-endo,6-endo,8,9,9,1 0,1 0-decachlorobornane
2-exo,3,3,5-exo,6-endo,8,9,9,1 0,1 0-decachlorobornane
2,5-endo,6-exo,8,9,1 0-hexachloroborn-2-ene
3,6,6,8,9,1 0-hexachloroborn-2-ene
3,5-exo,6,6,8,9,1 0-heptachloroborn-2-ene
2,3,5-exo,6-exo,9,1 0,1 0-heptachloroborn-2-ene
2,3,5-exo,6-exo,8,9,1 0,1 0-octachloroborn-2-ene
2,5-endo,6-exo,8,9,9,10,1 0-octachloroborn-2-ene
2,3,5,8,9,1 0-hexachloroborn-2,5-diene
2,2,3-exo,8,9,10(E)-hexachlorocamphene
2-exo,3-endo,8,8,9,1 0(E)-hexachlorocamphene
2-exo,3-endo,7a,8,9,10fE)-hexachlorocamphene
2,2,3-exo,8,8,9,10(E)-heptachlorocamphene
2,2,3-exo,8,8,9,9,10(E)-octachlorocamphene
2-exo,3-exo,6-exo,8,9,10,1 0-heptachlorodihydrocamphene
21
32
39
51
38
42a
42b
26
40
41
44
62
56
59
50
63
69
HxCB-3156
HxCB-3124
HpCB-6533
HpCB-6452
HpCB-6293
HpCB-4785
HpCB-4661
HpCB-3221
HpCB-3207
HpCB-3157
HpCB-5285
HpCB-2837
HpCB-4773
HpCB-2453
HpCB-2439
OCB-6964
OCB-6612
OCB-6549
OCB-6535
OCB-6460
OCB-6454
OCB-6453
OCB-5797
OCB-5301
OCB-4921
OCB-4917
OCB-4789
OCB-3223
OCB-2969
OCB-2965
OCB-2455
NCB-7047
NCB-6966
NCB-6965
NCB-6582
NCB-6551
NCB-6461
NCB-6455
NCB-5813
NCB-4925
NCB-4919
NCB-3261
DCB-7063
DCB-6967
DCB-6583
DCB-5975
DCB-3799
265-111
137-111
99-043
195-421
35-113
166-103
134-113
41-113
41-033
265-113
170-013
69-113
166-013
97-463
97-063
199-421
355-111
99-423
99-063
195-641
195-461
195-423
174-013
170-113
198-605
198-245
166-113
41-463
101-303
101-113
97-463
103-033
199-461
199-113
227-461
99-1 33
195-645
195-463
174-113
198-643
198-133
169-643
103-463
199-463
227-463
334-133
301-133
B6-913
B6-923
B7-499
B7-515
B7-560
B7-1026
B7-1059
B7-1450
B7-1453
B7-1462
B7-1572
B7-1 584
B7-1 592
B7-1712
B7-1715
B8-531
88-763
B8-786
B8-789
B8-806
B8-809
B8-81 0
B8-1 058
B8-1 252
B8-1413
B8-1414
B8-1440
B8-1945
B8-2075
B8-2078
B8-2229
B9-718
B9-742
B9-743
B9-1 011
B9-1025
B9-1 046
B9-1 049
B9-1 327
B9-1679
B9-2200
B9-2206
B10-831
B1 0-860
B10-1110
B10-1361
B10-1993
11
12
B[21001]-(1 11)
B[300301-01 2)
B[30030]-(012)
B[300121-(1 11)
B[300201-(1 12)
B[1 2022]-(102)
B[12002]-(1 12)
B[21020]-(1 12)
B[210201-)022)
B[210011-(1 12)
B[l 1022]-(012)
B[22010]-(1 12)
B[12022J-(012)
B120030]-1 12)
B[200301A022)
B[320121-(11 11)
B[300311-(11 1 )
B[300301-)1 12)
B[300301-)022)
B[30012]-(21 1)
B[300121-)1 21)
B[30012]-(1 12)
B[1 30221-(012)
B[1 1022]-(1 12)
B[1201 2]-)202)
B[12012]-(1 12)
B[120221-(1 12)
B[21020]-)122)
B[220301-(202)
B[220301-(1 12)
BR20030J-(122)
B[32030]-(022)
B[32012]-(121)
B[320121-(1 12)
B[30032]-(121)
B[30030]-(122)
B[30012]-(212)
B[30012]-(122)
B[13022]-(1 12)
B[12012]-(212)
B[12012]-(122)
B[21022]-(212)
B[32030]-(122)
B[32012]-(122)
B[30032]-(122)
B[1301 1]-(122)
B[23021]-(122)
E[1 001 2]-(111)
E[01003]-(1 11)
E(010231-(1 1 1 )
E[1 10221-(012)
E[1 10221-(1 12)
E[1 0012]-)122)
D[11010]-(1 11)
C[0320011-(1 1)
C[021001]-(21)
C[02101 1]-(1 1)
C[0320011-(21)
C[032001]-(22)
DC[022020J-(1 12)
aThe rules to determine the code according to Oehme and Kallenborn (79) are applied on the systematic names in the table; in the original reference, C8 and C9 positions
were swapped. Decoding the first part of this code gives a 9-digit binary number, which should be read from right to the left starting with the exo position! The code for the
C8 to Cl0 substitution was calculated according to Burhenne et al. ( 11) and Hainzl et al. (77). When the the chlorine substitution positions at these carbons were not given,the lowest possible number was chosen.
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will be part of the same coding system
without any class distinction; c) the theo-
retical number of chlorinated bornanes,
camphenes, and dihydrocamphenes will
require many thousands of codes, which
will be at least 4 digits. Presently, 17 chlo-
rinated bornanes and 5 chlorinated cam-
phenes have been assigned Parlar numbers
(Table 3).
A binary coding system for chlorinated
bornanes was proposed by Nikiforov et al.
(78). The possible chlorination positions
were ordered according to IUPAC order of
preference into a 13-digit binary number. A
" 1 " is assigned if a chlorine is present and a
"0", if not. This binary number is then con-
verted into a short 4-digit decimal number.
However, 5 of the maximum number of 18
substitution positions had to be fixed. This
was determined on the basis of the assump-
tion that environmentally important con-
geners have at least one chlorine at C10,
not more than two chlorines at C8, C9,
and C0O, and no chlorine at C4. Using this
assumption, the code can be limited to 4
digits instead of 6 but cannot be used for all
the theoretically possible congeners.
Applying the nomenclature to 2,2,5-endo,6-
exo,8,9, 10-heptachloroborane (Figure 2A)
results in the code HpCB-6452; these char-
acters are the acronym for heptachlorobo-
rane. However, the enantiomer given in
Figure 2B, which is chlorinated at positions
2-exo,3-endo,6,6,8,9,10, would have the
code HpCB-3188. Because the goal of the
IUPAC rule for systematic numbering is to
obtain the lowest possible number, the code
HpCB-3188 would be selected; this is an
incorrect systematic name. The most
important limitation of Nikiforov's sug-
gested system is that it is difficult to convert
between binary and decimal codes; a com-
puter is needed for rapid conversion. In this
case, the general code becomes:
212x 2-endo + 211 X 2- exo + 210 X 3-endo
+ 29 X 3-exo + 28x 5-endo+ 27 x 5-exo
+26x 6-endo + 25x 6-exo + 2x48a+23x 8b
+ 22 x 9a + 21 x 9b + 20 X (second chlorine
substituent to C1O)
Oehme and Kallenborn (79) also
proposed a nomenclature for chlorinated
bornanes based on a binary number repre-
senting all possible chlorination positions,
which was then converted to decimal code.
The positions at the six-membered ring and
at the three methyl groups are numbered
separately, which results in two 3-digit deci-
mal numbers at maximum, separated by a
hyphen. This was to prevent generation of a
code with a maximum of 6 digits, which
would be necessary if all possible positions
were included in a single code. For example,
the enantiomers in Figure 2 are represented
by the code 195-421; however, there is no
distinction between the enantiomers. The
advantage of this system over Nikiforov's
(78) is that related structures in Oehme
and Kallenborn's system have similar
codes. However, the basic bornane struc-
ture used by Oehme and Kallenborn is not
according to IUPAC rules because the C8
and C9 atoms are reversed (74). Care
should be taken when decoding the first
part of the code: the binary 9-digit number
must be read from the right to the left start-
ing with 2-exo. This was noted incorrectly
by Lau et al. (81), who were subsequently
cited in Nordic Council of Ministers (16)
and Wester et al. (37). Thus, decoding of
the 3-digit number to reveal the chemical
structure is not simple, and structural infor-
mation therefore is not directly available.
The general code becomes
20x 2-exo + 21 x 2-endo+ 22x 3-exo
+23x3-endo+24x4 +25x 5-exo
+ 26x 5-endo+ 27 x 6-exo+ 28 x 6-endo
(first part)
20x 8a + 21 x 8b + 22X 8c
(first digit second part)
20x 9a + 21 x 9b + 22 x 9c
(second digit second part)
20x 10a+21X 10b+22x 10c
(third digit second part)
Andrews and Vetter (74) proposed a
systematic nomenclature for chlorinated
A
Cl
Cl
Cl Cl
bornanes by listing them in order of prefer-
ence according to IUPAC rules. The con-
geners were split into a series of homologs to
restrict the code length to less than 5 digits,
which is necessary if all possible congeners
are tabulated by the method used for chlori-
nated biphenyls (82). With this method the
maximum number of digits is 4. The code is
preceded by a character to indicate whether
the compound is a bornane (B), camphene
(C), bornadiene (D), or bornene (E), and a
number denoting the degree of chlorination
(1-18). For example, the enantiomers in
Figure 2 are coded B7-515 and are distin-
guished by "a"- or "b"-, but b-coded enan-
tiomers correspond to incorrect structural
names (71) if IUPAC rules are applied. The
disadvantage of this method is that struc-
tural information can only be obtained after
consulting extensive tables or by using a
computer program that currently are only
available for chlorinated bornanes.
Wester et al. (37) proposed a nomen-
clature system that is a mixture of the
systems previously mentioned, with
advantages that the structural information
can be directly deduced and that the
nomenclature is applicable to chlorinated
bornanes as well as to chlorinated bor-
nenes and bornadienes. The proposed sys-
tem yields a code consisting of two parts.
The digits in the first part of the code
reflect the degree of chlorination of car-
bons C2 to C6, presented according to the
rules listed in Table 4. C4, i.e., the third
digit, can only have a code of 0 or 1. The
digits in the second part indicate the num-
ber of chlorine atoms of C8 to CIO. The
letter "B"precedes the 8-digit number in
the case of bornanes. For example, the
code for 2-endo,3-exo,5-endo,6-exo,8,8,9,
10,10-nonachlorobornane is B[12012]-
(212). The code for the conformation of
B
Cl
Cl Cl
Figure 2. (A) and (8) show the two enantiomers of 2,2,5-endo,6-exo,8,9,10-heptachlorobornane.
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Table 4. Codes indicating chlorination of C2 to C6
atoms of chlorinated bornanes.
Endo Exo Code
o 0 0
1 0 1
O 1 2
1 1 3
the enantiomer would be B[21021]-(122);
this clockwise numbering is arrived at by
reversing the first part of the code and
exchanging the digits for the C8 and C9
positions. Hence, according to the
IUPAC rules, B[12012]-(212) is the only
correct representation for both enan-
tiomers. To differentiate both enan-
tiomers "r" is proposed for clockwise
numbering of the six-membered ring
(Figure 2A; B[30012]-(11 1)r ) and "s" for
counterclockwise numbering (Figure 2B;
B[30012]-(1 1 1)s ), provided the bridging
carbon atom, C7, is above the ring. The
advantage of this notation is that it is
related to the generally accepted notation
for chirality (R/S), and enantiomers
receive the same code. For racemates, the
r/s notation can be left out.
Another advantage of this system of
nomenclature is the simplicity of establish-
ing whether a congener has an enantiomer.
For example, 2,2,3-endo,5-endo,6,6,8,9,10-
nonachlorobornane, coded as B[31013]-
(1 1 1), has no enantiomer. Reversing the
first part of the notation and exchanging
the digits representing the number of chlo-
rine atoms at the C8 and C9 positions
gives the same code.
Wester et al. (37) extended their
nomenclature to indude bornenes and bor-
nadienes, which is easily done because of
structural similarity. Only one chlorine
atom can be attached to a carbon atom
participating in a double bond. Only a "0"
or "1" can be assigned to such a carbon.
For example, 2,5-endo,6-exo,8,9,9,10,10-
octachloroborn-2-ene will be coded
E[10012]-(122) and 2,3,5,8,8,9,10-hep-
tachloroborna-2,5-diene will be coded
D [ 1 1010]-(21 1). The r/s nomenclature
can be used if there are enantiomers; it is
not used in the case of a racemic mixture
or if there are no enantiomers.
Polychlorinated camphene and dihy-
drocamphene structures could not be rep-
resented by codes based on the system
previously described because of the large
differences among structures. However,
Wester et al. (80) developed a coding sys-
tem analog to their system for bornanes,
bornenes, and bornadienes (37). The
122
numbering of the carbon atoms in the
skeleton is the same as that proposed by
Hainzl (83); however, the "a" and "b"
indications of the substituents at CI0 (63)
have been replaced by "'E" (trans) and "Z"
(cis), respectively (Figure 2A). As seen in
Figure 1, this method bears a strong resem-
blance to the clockwise numbering of the
bornane carbon skeleton (37).
Figure 1D illustrates that it is not
necessary to consider carbons C5 and C6
because they cannot be chlorinated. The
first part of the code concerns the sub-
stituents at carbons Cl to C4, C7, and
CG0. Carbons C1 and C4 can only have
one chlorine substituent and these invari-
ably will be in the endo position. Sub-
stitution at carbons C2 and C3 can be
denoted according to the rules of Table 2.
For carbon C7, the positions of the
substituents must be defined. A "0" is
assigned for no substitution, "1" for sub-
stitution in the "a" position, "2" for sub-
stitution in the "b" position, and "3" for
two substituents. For ClO the known
"E"(trans) nomenclature corresponds with
code 1 and "Z" (cis) with code 2. Carbons
C8 and C9 are dealt with in the second
part of the proposed code, which merely
reflects the number of chlorine sub-
stituents at C8 and C9. Finally, the code is
preceded with a "C" for camphenes (74),
with enantiomers being distinguished by
an "r" or "s"according to Wester (37).
The general code then becomes
C[code C1, code C2, code C3, code C4,
code C7, code C10]-(code C8, code C9)r/s.
The same logic used previously can be
applied to the dihydrocamphenes (Figure
1E). There is no need to consider carbon
C5, as chlorination cannot occur. For the
first part of the code, the same rules are
applied for carbons Cl to C4 and C7 as
for the chlorinated camphenes. Carbon C6
can only have one substituent, which can
be in the endo or exo position, and the rules
in Table 2 were applied. However, if C6 is
not chlorinated, the position of its hydro-
gen atom is unclear, in which case a sub-
script selected according to the rules of
Table 2 is used to denote the endo or exo
position of the hydrogen atom. The second
part of the code deals with C8 to Cl0,
with the code reflecting the number of
chlorine substituents. Finally, the code is
preceded by DC (dihydrocamphenes) and
enantiomers are distinguished by adding an
"r" or "s" according to Wester (37). The
general code then becomes
DC[code Cl, code C2, code C3, code C4,
code C6H6, code C7]-(code C8, code C9,
code C1O)r/s.
Analytical Methods
Mostly toxaphene levels are determined
that may lead to a large over- or under-
estimatation of the true concentration, as
the peak pattern of the sample under studydoes not resemble that of the standard.
Peak patterns may be considerably altered
in the environment (84,85), but there also
are large differences among standards for
the commercially available technical
toxaphene. Using various technical stan-
dards, Carlin and Hoffman (86) found
variations between 19 and 131% compared
to their laboratory standard. Furthermore,
detector response generally is not equal for
all congeners. The most relevant question
may be: What does a total concentration
imply when the composition is unknown?
Because of this the trend at present is
toward using congener-specific approaches,
which is possible after the first isolation
and synthesis of individual compounds(87,88). Currently, about 30 individual
congeners are commercially available. For
comparison of monitoring results, it is
important that authors report the full ana-
lytical procedure used, as different methods
can yield large variations in results, which
could lead to incorrect conclusions.
Exration
Little attention has been paid to the
efficiency of extraction procedures. How-
ever, it is thought that extraction procedures
suitable for related compounds such as
PCBs, DDT, and chlordanes could also be
used for toxaphene compounds because of
lipophilic and structural similarities (73).
Pre-Sparaton and Clean-Up
Several stationary phases have been used in
the sample preparation for residue analysis.
Aluminium oxide (89) and gel permeation
chromatography (GPC) (90) or a combi-
nation of the two (91-93) can be used to
remove lipids from the sample. Florisil(48,90,94) and silica gel (7,89,95) can be
used for further fractionation of the
extract. Reversed-phase chromatography(C8 and C18) can also be used to isolate
B[12012]-(202) and B[12012]-(212) from
environmental samples.
Zu et al. (68) noted that silica gel
preparation can be used to obtain separa-
tion of technical toxaphene over a wide
range and that B[12012]-(202) can be
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detected free from coeluting compounds
after the preparation. The elution order of
individual chlorinated bornane congeners
on silica gel is B[12012]-(202) <<
B[21020]-(022) < B[12012]-(212) <<
B[20030]-(122) < B[12012]-(112) <<
B[21020]-(122) < B[30030]-(122) <<
B[32012]-(111) << B[30012]-(211) +
B[30012]-(121) << B[30030]-(111) (96).
The elution order of several individual
toxaphene congeners on reversed-phase
HPLC was recently presented (97).
When silica fractionation is used, indi-
vidual congeners should be used to estab-
lish the volume range of the toxaphene
fractions and to evaluate recoveries; low
recoveries for certain congeners may occur
when only a technical mixture is used for
optimization (69,98). de Boer et al. (69)
used columns of 2.5 g SiO2'2% H20
(w/w); most of the toxaphene compounds,
including the most relevant congeners,
were eluted in a second fraction of 12 ml
diethyl ether/iso-octane (20:80, v/v) after
a first fraction of 13 ml iso-octane that
contained mostly PCBs. Only 1 to 2%
PCBs were present in the toxaphene frac-
tion, which did not seriously interfere
with the toxaphene quantification using
ECD. The entire clean-up procedure
resulted in recoveries of 80 to 96% for
total toxaphene, and 84 to 100% for
B[30012]-(111), B[12012]-(212), and
B[30030]-(122). B[12012]-(202) was
divided over the two fractions (about 40%
in the first fraction and 60% in the second
fraction), with an overall recovery of 85 to
95%. In a collaborative study to determine
four bornane congeners in fish oil, gel per-
meation was used followed by adsorption
chromatography on silica gel (99). The sil-
ica gel clean-up was performed using 1.0 g
silica deactivated with 1.5% water. The
toxaphene compounds were collected with
the PCBs and some organochlorine pesti-
cides in the first fraction and eluted with
8 ml hexane/toluene (65:35, v/v). Although
the results of this study were obtained
using GC-ECD, the recoveries were 77 to
100%, and the relative standard deviations
of reproducibility were 18 ± 4, 24 ± 5,
29 ± 19, and 21 ± 5% for B[12012]-(202),
B[12012-(212), B[30030]-(122), and
B[30012]-(1 1 1), respectively. Some partic-
ipants preferred a clean-up in which the
toxaphene compounds and PCBs are sepa-
rated according to Alder and Vieth (92).
They eluted the silica column before the
hexane/toluene fraction with 8 ml hexane
in which the PCBs and p,p'-DDE were
recovered. Some chlordane/nonachlor and
p,p'-DDT and B[12012]-(202) were also
found in that fraction. Krock et al. (96)
improved on this method by using 8.0 g
activated silica. The sample was eluted with
48 ml hexane to remove PCBs. This was
followed by elution with 50 ml hexane/
toluene (65:35, v/v) in which the toxaphene
compounds were recovered.
Injection
Alder et al. (100) reported that injector
temperature should not exceed 513K
because severe decomposition of com-
pounds may take place. Bartha et al. (101)
recommend an injector temperature below
523K. Care should be taken with active
sites in the liner and the injector. It is rec-
ommended that the optimal temperature
be verified by a series of simple tests, as
there is much variation in injector geo-
metry. Alawi et al. (102) showed that
response factors obtained using splitless
injection are lower than those obtained
using on-column injection.
Bartha et al. (101) reported that using
pressure pulse injection (PPI) at 498K
resulted in response factors 4 times that of
those obtained with splitless injection. This
was especially significant for compounds
with a low vapor pressure and long reten-
tion times [e.g., B[30030]-(122)] (101).
With this technique, the time the com-
pounds spend in the injector is short, so
there is less chance of degradation.
Gas Chromatographic Separation
Table 5 gives the elution order of
toxaphene compounds for various sta-
tionary phases. The relative nonpolar
stationary phase, 5% diphenyl, 95%
dimethylpolysiloxane (DB-5 [J&W
Scientific, Folsom, CA; Sil-8 [Chrompack,
Middleburg, The Netherlands]; Ultra-2
[Hewlett Packard, Palo Alto, CA]), col-
umn with lengths of 30 to 60 m and
diameters of 0.15 to 0.32 mm ID is most
frequently used. However, more polar
columns are often used to validate the
results, e.g., 14% cyanopropylphenyl,
86% dimethylpolysiloxaan (DB-~1701
[J&W Scientific]; Sil-19 [Chrompack])
(107), and 6% cyanopropylphenyl, 94%
dimethylpolysiloxaan (DB- 1301 [J&W
Scientific]) (99).
Krock et al. obtained a relatively good
separation using a very nonpolar Sil-2 sta-
tionary phase (comparable to squalene)
(96), the same elution order as on the
more polar DB-5 columns was found
(103). The CP-Sil 2 phase was successfully
used to a temperature as high as 563K,
although the supplier advised a maximum
temperature of 473K. No alteration of
retention times was observed after analysis
of several hundred toxaphene compounds
on this phase (101). After comparing the
retention times of B[12012]-(202) with
B[12012]-(112) and B[30030]-(022) with
B[30030]-(112), it was suggested that
compounds with one chlorine on both C8
and C9 elute much later from this phase
than compounds with two chlorines on
one of these carbons. Furthermore, by com-
paring B[12012]-(202) with B[03003]-
(202) and B[12012]-(1 12) with B[30030]-
(112), it was found that compounds with
alternating endo-exo substitution elute ear-
lier than compounds with two chlorines at
C2 and C5 (103).
Nikiforov et al. (106) split the bornane
skeleton into two parts, the six-membered
ring, "Ring," and the three methyl groups,
"Metil." By comparing available retention
indices (RI) to those from a DB-5-type
phase with the substitution of these two
parts of the molecule, several correlations
were found and the following conclusions
were drawn:
1. The RI of compounds with either the
same Ring or Metil increases with
increasing degrees of chlorination of the
other.
2. For all Metil substitutions the RI
increases with the following Ring sub-
stitution: [12012] < [30012] < [30030]
< [21022].
3. For all Ring substitutions the RI
increases with the following Metil sub-
stitution: (202) < (1 12) and (21 1)
< (1 12).
The use of heart-cut multidimensional
gas chromatography (MDGC) (108) offers
a possibility to overcome coelution prob-
lems due to the large amount of congeners.
By transferring heart-cuts from a separation
performed on a DB-5-type phase to a 15%
dimethylsilicone, 85% polyethylene glycol
(DX-4; J&W Scientific) phase, in addition
to a polyethylene glycol terephthalic acid
ester (FFAP; Hewlett Packard) and a 10%
cyanopropyl, 90% biscyanopropyl poly-
siloxane (Rtx-2330; Restek Corp.,
Bellefonte, PA) phase for further separation
(a multidimensional set-up) (69), a large
number of peaks were observed in the sec-
ondary chromatograms, which indicated
that the resolution offered by a single col-
umn is insufficient and can easily contribute
to false-positive results, especially when non-
selective ECD is used for quantification.
There were no large differences between the
column combinations; the DB-5-Rtx-2330
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Table 5. Elution order reported in the literature for several stationary phases.a
Sil-2b DB-5, Sil-8, Ultra-2cd Ultra-2e Smecticc Rtx-2330cf Chiralc DX-4f FFAPf
C[032001 111 1 ) B[30030-(012) B[120121(202) B[1201 21-(202) B[1 201 2]-(202) B[120121-(202)
C[0210011-(21) B[120121-(202) B[300301-(012) C[0320011-(21) B[120121-(212) B[12012]-(212)
C[02101 1 -l 1) B[200301-(022) C[032001H21) + B[32012]-(1 11) C[032001]-(22) B[300121-(1 11 ) B[300121-(1 11)
B[30030]-(012) 3[3003011012) C[032001 -22) B[320301-(112) B[210201-(122) B[30030]122) B[30030]-(122)
B[210201-(022) C[032001]-(21) + B[30030]-(022) B[300301-(022) B[300301-(012)
B[120121-(202) B[120121-(202) [11201211202) B[300121-(1 11) C[0320011-(22) B[32012]-(1 11)
B[30012]-(1 1 ) B[300121-(1 11) B[30012]-(1 1 1) B[32012]-(1 11) B[12012]-(212) + B[12012]-(112)
B[300301-(022) + C[032001]-(22) B[2102211 1) B[200301-(122) C[032001]-(21) B[1 2012]-(212)
B[120021-(1 12) B[210201-(122) B[20030]-(122) B[300121-(1 1 1)
B[220021-(1 12) + B[30012]-(121) B[30012]-(212) B[300121-(21 1)
B[21002]-(1 12) + B[30012]-(21 1) B[210201-(122) B[200301-(122)
B[30030]-(022) 3[12012]1212) B[300121-(1 11) B[300121-(121)
B[320121-(1 1 1) B[320121-(1 1 1) B[320121-(1 1 1) B[120121-(1 12) B[300301-(122) B[300301-(022)
B[12012]-(112) B[120121-(1 12) B[12012J-(112) B[320301-(1 12) B[300321-(122) B[320301-(1 12)
B[21020]-(122) B[210201-(122) B[210201-(122) B[300121-(212) B[120121-(112) B[300121-(212)
B[30012]-(21 1) B[300121-(21 1) B[300121-(21 1) B[30030]-(112) B[300301-(112) B[30030]-(112)
+ B[30012]-(121) + B1[30012-(1 21) B[300121-(121) B[300301-(122) B[30030]-(122)
B[20030]-(122) B[200301-(122) B[200301-(122)
B[300121-(1 12)
3[1 20121-(212) B1l 2012]-(212) B[1 2012]-(212)
B[230211-(202)
B[30030]-(112) B[300301-(1 12)
B[32030]-(022)
B[320121-(121)
B[320121-(1 12)
B[23021]-(1 12)
B[30012]-(212) B[300121-(212)
B[32030]-(112) B[320301-(1 12)
B[300121-(122) B[300121-(122)
B[300301-(122) B[30030]-(122) B[300301-(122)
B[21022]-(212) B[210221-(212) B[220121-(212)
B[300321-(121)
B[32012]-(122)
B[230211-(122)
B[30032]-(122) B[30032]-(122)
B[32030]-(122)
'Sil-2, similar to squalene; DB-5, 5% diphenyl, 95% dimethylpolysiloxane; Smectic, N,N'-bis(p-butoxy-benzylidene)-cz,a'-bis-p-toluidine; Rtx-2330, 10% phenylcyanopropyl
90% biscyanopropyl polysiloxane; Chiral, 10% heptakis(2,3,6-0-t-butyl-dimethylsilyl-P-cyclodextrin in OV-1701-OH; DX-4, 15% dimethylsilicone, 85% polyethylene glycol;
FFAP, polyethylene glycol terephthalic acid ester. bData from Vetter et al. (103). cData from Baycan-Keller and Oehme (104). dData from Coelhan et al. (105). *Data from
Nikirov et al. (106). fBased on the measurements of de Boer et al. (69).
combination was preferred because of its
somewhat better separation but mainly
because of its low bleed. However, Baycan-
Keller and Oehme (109) observed deg-
radation of B[32012]-(111), B[30012]-
(211), B[30012]-(121), B[30012]-(212),
B[30030]-(122), B[12012]-(212), and
B[32030]-(112) on the Rtx-2330 phase.
Reevaluation of the multidimensional
heart-cut data of de Boer et al. (69)
showed that the standard of B[12012]-
(212) has the same profile (a broad hump
eluting with the analyte peak) as that
described by Baycan-Keller and Oehme;
this could have been caused by decomposi-
tion on the stationary phase. However,
normal peak shapes were obtained for
B[12012]-(202), B[30012]-(111), and
B [30030]
-(122). Karlsson and Oehme
(107) also mention the possibility that the
low response of B[30030]-(122) is due to
losses on the polar Rtx-2330 phase.
Alder et al. (100) found that B[12012]-
(202) and B[30030]-(122) were decom-
posed to a great extent on the highly polar
DX-4 phase. de Boer et al. (69) did not
observe degradation effects on this phase;
this was also true after reevaluation of data
and further experiments with this stationary
phase (Figure 3). This may be partly because
a shorter column was used (15 m instead of
30 m), which limits exposure time of the
components to a high temperature, 493K.
It is extremely time consuming to
analyze several compounds in a complex
sample using a multidimensional set-up,
even when a system is available that has sev-
eral parallel traps for storage of heart-cuts
(108). If the speed of the secondary separa-
tion is high enough to separate a cut from
the first dimension while the next cut is
being collected, it will then be possible to
record a connecting set of secondary chro-
matograms. The complete two-dimensional
chromatogram can be constructed from the
secondary chromatograms, similar to that
in thin-layer chromatography. A method
with this capability is called comprehensive
(110). A comprehensive separation uses the
whole two-dimensional separation space to
generate resolution provided that the indi-
vidual separations are based on different
interactions (i.e., are not correlated). For a
method to be comprehensive, it is neces-
sary that the first dimension be sampled at
least every peak width by the second sepa-
ration dimension. The first dimension can
then be constructed from the secondary
chromatograms (111,112). Research to
make this powerful separation technique
available for toxaphene analysis is currently
under investigation.
Detection
Using MS detection would overcome some
problems of coelution, in addition to those
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higher response factors because of their
aromatic character. Andrews et al. (113)
cbl12 used high resolution MS in the selected
l B[720121-H202) l ion monitoring (SIM) mode at m/z
B[120121-(212) 158.8768 and 160.9739 with EI as the
\ /1 ionization method used to obtain a total
B[300030]-(122) chlorinated bornane result without inter-
ference from other compounds. However,
this approach is less sensitive than the NCI
mode and does not distinguish between
homolog groups. NCI offers both selectiv-
l \\ ity and sensitivity for bornane congeners
\ | \ 0 \ 0 ~~~~~~~~~~~~(ll4)but does not offer the possibilit,v of
structure elucidation.\ l5l x 5 1 NCI is the most widely used MS detec-\ x 5 > tion method for toxaphene, but it is insen-
, , , sitive to lower chlorinated congeners. The
35 40 45 50 55 60 65 70 EI mode is more sensitive to lower chlori-
Minutes nated and, consequently,
additional 25 peaks from lower chlorinated
compounds were found with EI than with
NCI (68). Often both the M- and (M-Cl)-
B[12012]-(212) ions are monitored (67,101). Problems
B[120121-(202) with GC-NCI/MS in the SIM mode
l N/1 include the formation of (M-OCI)- frag-
ments of PCBs; false-positive signals may
be caused in part by chlordanes and the
appearance of higher chlorinated bornane
congeners (67,73,115). Krock et al. (96)
I 11 1 l1 I | I 1 I did not observe the interfering oxygen
B[3000301-122) adducts of PCBs, which have only been
reported to occur when small leakages are
Bl30003r E /present in the MS (96). Good linearity
cbl12 over four orders of magnitude for five chlo-
Minutes
Figure 3. Heart-cuts of chlorobornanes B[12012]-(202), B[12012]-(212), and B[30030]-(122) in (A) a commercial
standard and (B) a Hake liver extract. Upper traces show separation on the first column (DB-5); lower traces show
separation of the heart-cut peaks on the second column (DX-4).
caused by compound class or the degree of
congener chlorination. Coelution with
compounds having similar fragmentation
patterns may well occur in the electron
impact (El) mode and will lead to false
positive results. Structural information is,
of course, much more limited in the NCI
mode. The ECD is an attractive alterna-
tive detector, however, and as ECD is less
selective than MS detection, an even more
efficient separation will be necessary.
The profiles obtained with flame ion-
ization detection are similar to those
obtained with full-scan El/MS and have a
low response dependency on the chlorine
substitution pattern; however, only the
latter technique has the selectivity and sen-
sitivity necessary for residual analysis (92).
NCI/MS has a completely different peak
profile that is probably caused by the
higher variation in response factors for
individual congeners (11).
When using the ECD, removal of
interfering compounds is a prerequisite.
PCBs, for example, are present at high
concentrations in most environmental
samples, which may also contain toxa-
phene compounds. In addition, PCBs have
rinated bornane congeners was obtained
using NCI/MS (102). It was tentatively
found that a 2,2,5,5 substitution of
chlorobornane congeners ([30030]) had a
negative effect on the NCI/MS response
(81,116).
Buser and Miiller (15) used tandem
MS/MS with EI to identify B[12012]-
(202) and B[12012]-(202) in penguin and
harbor seal samples. Most toxaphene con-
geners produce fragments with m/z= 125
under El conditions; this ion, together with
ions at m/z= 159, 195, and 231, is consid-
ered to be characteristic of toxaphene con-
geners (62). In contrast with quadrupole or
double focusing MS/MS in which tandem
mass spectrometry is accomplished through
space, Saturn 4D MS/MS uses the time
dimension to accomplish MS/MS. The iso-
lation of precursor ions and further dissoci-
ation takes place in the same chamber (m/z
locking) but at a different time. This
reduces loss of precursor ions and hence
provides better sensitivity. The major ion in
the daughter spectrum of m/z= 159 is a
fragment at m/z= 125. However, PCBs
and some organochlorine compounds also
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produce this fragment in the MS/MS
mode. Therefore, it would appear that the
ion at m/z = 89 (dechlorinated mono-
chlorotropylium ion), which orginates
from the m/z= 125 ion, would be more
useful for quantification of toxaphene con-
geners (117). However, coelution of com-
pounds that produce this ion cannot be
observed. Furthermore, the response fac-
tors with this method vary considerably for
individual cogeners [B[12012]-(202) 2.3;
B[30012]-(111) 3.2; B[12012]-(212) 0.7;
B[30030]-(122) 0.7; technical mixture
1.7)]. The authors suggest that because
their results were all lower than the aver-
age, results in a round robin test in which
they took part (98) could be explained by
the specificity of their method.
Alder and Vieth (92) determined the
toxaphene concentration in a standard ref-
erence sample (SRM 1588) on the basis of
three indicator congeners using GC-ECD.
They found a total toxaphene concentra-
tion of about 1600 pg kg-'. In contrast to
this result, Fowler et al. (118) obtained a
value of 5410 pg kg-' in the same sample
using GC-NCI/MS. Alder and Vieth then
reanalyzed the sample using NCI/MS and
obtained a value of 5210 pg kg-1, which is
close to the value reported by Fowler et al.
(118). They concluded that this large
difference between the concentrations
found is caused by the large difference in
response factors between congeners with
NCI, which gives a positive bias to the
results when they are compared with those
using ECD, which has a smaller difference
between response factors. Rantio et al.
(48) also showed that NCI/MS gave
generally higher results than ECD.
However, the results demonstrated a lin-
ear relationship between the two detection
techniques, which made it possible to
compare the result obtained. A higher
response for NCI/MS was also reported
by Wideqvist et al. (46), especially when
the degree of chlorination was higher. In
contrast, Xu et al. (119) found that
GC-ECD gave results identical to those
for GC-NCI/MS for quantification of
individual chlorobornanes in fish samples.
A possible explanation for these, which at
first are contradictory observations, could
be different standards used in combination
with the detector, which could influence
the result to a large extent, as shown by
Carlin and Hoffman (86). For example, it
is possible to obtain the same results for
GC-ECD and GC-NCI/MS with one
standard, but largely differing results with
another. Another explanation can be
differences between the MS configuration
used in the studies.
ECD determination of total toxaphene
is subject to insufficient selectivity, whereas
NCI/MS is subject to variable response fac-
tors. Using indicator compounds as a basis
for calculation of total concentration was
suggested as a way to obtain precise and
comparable data (92). However, this
approach can only be used successfully
when the indicator compounds do not
coelute with other compounds. Coelution
of suggested indicator compounds was
shown by heart-cut multidimensional gas
chromatography (69). Depending on the
sample type, up to 10 peaks were found
when the analyte peak was further sepa-
rated on a second, different column. For
B[12012]-(202) and B[30030]-(122), the
area fraction of the compound in its first
dimensional peak was between 20 and
85%, whereas that for B[12012]-(212) was
85 to 95%. Therefore, only B[12012]-
(212) can be determined reliably after a
one-dimensional separation. However, it
must be noted that most samples analyzed
were from organisms relatively high in the
food chain.
Enantiomers
Usually enantiomer ratios (ERs) are used
to express the ratio in which the enan-
tiomers are present. The peak area/height
of the (+)-enantiomer is divided by that of
the (-)-enantiomer (120-123). When the
conformation of the enantiomers eluting
from a chromatographic system is not
known, as with enantiomers present in
toxaphene, the ER is often expressed as the
peak area/height of the first eluting enan-
tiomer divided by that of the second
(124). Using the quotient of the two
enantiomers gives an undefined result
when the second enantiomer is not
detected. de Geus et al. (125) observed this
and therefore divided the second enan-
tiomer by the first. Of course, this approach
only shifts the problem. It would be better
to divide by the detection limit (which does
not equal zero) when a compound is not
found, but this can lead to very high or low
numbers. In addition, because of the recip-
rocal-like scale, ERs larger than unity
appear to deviate more than ERs smaller
than unity (e.g., 6.7 and 5.0 vs 0.15 and
0.20). To avoid these disadvantages, the
(+)-enantiomer or the first eluting enan-
tiomer can be expressed as a proportion of
the sum of the two (126). This enantiomer
fraction (EF) is 50% if both enantiomers
have the same abundance. Advantages of
using EFs are an understandable linear scale,
dividing by zero or very high and low values
does not occur, and similar enantiomer pro-
portions are distinguished more easily.
Deviations from the racemic value have the
same magnitude in both directions.
Most of the compounds in toxaphene
are chiral. Since bioaccumulation and
metabolism in biota are often different for
enantiomers, a change in the EF can be
expected during disposition in the food
chain. Furthermore, enantiomers often
have different toxic properties. The deter-
mination of EFs in biota can give an indi-
cation about whether a specific biologic
mechanism changes the ratio in the course
of disposition in the body. A significant
deviation from the EF value present in the
technical mixture (usually 50%) suggests a
specific metabolic transformation of one of
the enantiomers. On the other hand, an
equal EF points to biologic persistence
(124). Comparison of the EFs of different
congeners in combination with their mole-
cular structures can help us gain insight
into the metabolism of these compounds.
When determining EFs of chlorinated
bornanes in biota, the possibility cannot
be excluded that the values found are not
merely due to metabolism in the species
studied because a change during previous
disposition in the food chain is also possi-
ble. Feeding studies in which the species
of interest is exposed to (racemic) mix-
tures of known composition would elimi-
nate this problem. As an alternative, in
vitro assays can be used in which micro-
somes are incubated with the compounds
of interest. The microsomes contain the
cytochrome P450-dependent mono-
oxygenase enzyme systems involved in
enantioselective and nonenantioselective
biotransformation. Boon et al. (127,128)
successfully used such an approach to
study the a-chiral biotransformation of
toxaphene congeners by microsomes from
harbor seal, whitebeaked dolphin, sperm
whale, and laysan albatross.
Separation should be enantioselective as
well as isomer specific to determine EFs.
Unfortunately, this doubles the number of
peaks to be separated (125). A tert-butyl-
dimethylsilylated P-cyclodextrin phase,
introduced by Blum and Aichholz (129),
has been shown to give a good enantiomer
separation of toxaphene compounds
(15,104,124,125,130). However, enan-
tiomer separation of bornane congeners is
still a rather empirical task and the selec-
tion of a convenient stationary phase is
determined primarily by trial and error
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(131). It has been shown that columns
based on heptakis(2,3,6- 0- tert-butyl-
dimethylsilyl)-,-cyclodextrins are especially
suitable for the separation of polychlori-
nated bornane enantiomers (15,124,
132,133). Unfortunately, this stationary
phase is not very well defined and batch-
to-batch differences have been observed
(134). Vetter et al. (135) compares several
enantioselective phases for the separation
of toxaphene compounds.
The obtainable enantiomer resolution
depends on the column oven temperature
profile. It was found that this phase can be
used up to a temperature of 535K in a
programmed run. However, at lower
temperatures the obtained resolution is
much higher (130). Baycan-Keller and
Oehme (104) showed that a temperature
ramp of 1K resulted in much better separa-
tions compared to one of 10K. This was
also found by de Geus et al. (125). Unfor-
tunately, slow temperature programs lead
to very long run times, which can be a
problem when compounds with low
concentrations must be detected.
Most attention has been devoted to
measuring the EFs of B[12012]-(202) and
B[12012]-(212) (Table 6) (15,137).
However, studies by Vetter et al. (130)
and de Geus et al. (125) show that other
compounds can be much more interesting
Table 6. Enantiomer fractions.a Percentage of several chlorinated bornanes in seal blubberb and several other
species.c
Compound
Sample B[12012H202) B[12012]-(1 12)
Seal blubber (n= 10) 50.59 ± 0.56 51.43 ± 0.78
Herring (Baltic Sea) 48.7 ± 0.8 51.9 ± 0.7
Herring (North Sea) 51.5 51.9 ± 0.7
Mackerel (North Sea) 53.0 ± 2.6 52.6 ± 0.7
Mackerel (North Atlantic) 49.5 ± 0.8 51.9 ± 0.7
Halibut (North Atlantic) 47.6 ± 2.2 51.9 ± 0.7
Redfish (North Atlantic) 52.4 ± 2.3 51.9 ± 0.7
Saithe (North Atlantic) 51.9 ± 0.7 51.7 ± 0.7
Farmed salmon (Norway) 50.5 ± 1.5 53.0 ± 0.9
Monkey adipose tissue 56.3 ± 1.9 59.0 ± 0.8
Monkey adipose tissued 56.7 ± 0.6 57.4 ± 0.6
Human milk A 56.1 ± 1.7 51.5 ± 0.7
Human milk B 56.1 ± 0.8 53.9 ± 0.6
Human milk C 53.9 ± 2.1 55.2 ± 1.2
Human milk D 55.2 ± 2.0 54.8 ± 0.8
Human milk (pooled sample) 51.7 ± 1.2 57.1 ± 0.6
'Enantiomer fraction is the abundance of the first eluting enantiomer relative to the abundance of the sum of both
enantiomers (126). hData from Kallenborn et al. (124). cData from Alder et al. (136). didentical extract determined
with GC-ECD.
because they show more enantioselective
activity (Table 7).
Parlar et al. (139) report that all parent
compounds in toxaphene occur as race-
mates. Buser and Muller (140) showed
that some compounds are present in the
technical formulation (Melipax) in non-
racemic compositions. However, interfer-
ences from other compounds cannot be
exduded, even in the MS/MS method they
used. Vetter et al. (130) isolated the com-
pound B[21020]-(022) from Melipax. The
mass spectrum of this compound showed
no significant impurities; however, the first
eluting enantiomer was significantly more
abundant than the second. The EF was
55.8 ± 0.6%. Furthermore, the authors
showed that the EF of this compound was
50.0% in a cod liver extract from the
Baltic. If a synthesized standard with a
racemic composition were used, it might
be concluded that no enantioselective
process took place. This demonstrates the
importance of carefully choosing the stan-
dard. On the other hand, deviation of this
compound from the racemic value should
also appear in other technical formulations
because Melipax accounts for only 5% of
the global toxaphene production (141) and
B[21020]-(022) and the contribution of
B[21020]-(022) to Melipax is < 1% (130).
Parlar et al. (139) document EFs of
several chlorinated bornanes in cod liver
oil, herring, halibut, caviar, and redfish
samples obtained from Karlson and
Oehme (107), Kallenborn et al. (124),
and Alder et al. (136). The EFs show little
variation-50.2 ± 1.2%; therefore, Parlar et
al. conclude that no significant degradation
of toxaphene enantiomers takes place in
Table 7. Enantiomer fractions.a Percentage reported in the literature.
Compound
Sample B[1 20121-(202) B[120121-(212) B[200301-(022) B[200301]022) B[21001]-H1 12) B[300301-(022) B[300301-(122)
Data from Vetter et al. (130)
Weddell seal (female, subadult) 52 55 77
Weddell seal (male, adult) 55 57 72
Weddell seal (male, adult) 52 57 74
Leopard seal (unkown, adult) 57 62 81
Data from de Geus et al. (125)
Hake liver (pooled, male and 53.5 52.9 ND ND 87.7 74.1
female, 1989-1991, Ireland)
Dolphin blubber (40-year-old 51.6 100 ND >95 76.9
male, 1990, southern North Sea)
Dolphin blubber (10-year-old 51.0 ND >95 80.0
male, 1990, southern North Sea)
Data from Parler et al. (138)b
Cod liver oil 50.0-58.5 50.0-52.6 52.4-56.1 50.2-52.2
Fish oil 50.0-52.2 50.2-50.5 54.6-56.1 63.6-65.4
ND, not detected. 'Enantiomer fraction is the abundance of the first eluting enantiomer relative to the abundance of the sum of both enantiomers (126). bSamples were
obtained from different countries.
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fish. Unfortunately, Kallenborn et al.
(124) and Alder et al. (136) present other
EFs (Table 6) and Karlsson and Oehme
(107) do not present EFs. The data
in Table 6 are only for B[12012]-(202)
and B[12012]-(212); the mean EF is
53.1 ± 2.7%, which is not a large deviation
from the racemic value. In a recent study
Parlar et al. (138) show that B[20030]-
(122) and B[30030]-(122) show EFs devi-
ating from the racemic value in cod liver
oil and fish oil (Table 7). B[12012]-(202)
and B[12012]-(212) have EFs near the
racemic value, but in one cod liver oil
sample a deviating value is found for
B[12012]-(202), 58.5%. That sample is
subject to further study.
The results of Alder et al. (136) show
that the EF value of these compounds in
warm-blooded species (human milk and
cynomologus monkey adipose) deviate
from unity. This is in accordance with the
observed EF of 57.3% for B[12012]-
(212) in Antarctic penguins by Buser and
Muller (140). This could indicate a more
efficient metabolism present in these species
compared to that in other species (fish).
Intedabowry Study
A German collaborative study (142) with
contaminated milk fat undertaken in the
mid-1980s demonstrated the analytic diffi-
culties and uncertainties in analysis of tech-
nical (total) toxaphene by packed column
GC-ECD. Andrews found that in many
laboratories only about 15 to 30% of
toxaphene components were eluted from
silica or Florisil columns with a nonpolar
solvent. This was thought to be the main
source of the large variation between labo-
ratories (98). In a German intercalibration
experiment, recoveries of 77 to 100% with
a relative standard deviation of repro-
ducibility of 23 (9.2-50.5%) were found
for four indicator compounds in a fatty
matrix. On the basis of these results, the
method was recommended for routine
analysis in food inspection in Germany
(99). In a recent QUASIMEME (Quality
Assurance of Information for Marine
Environmental Monitoring in Europe)
laboratory performance study with four
toxaphene congeners in standard solu-
tions, most of the 15 participants reported
satisfactory results (143).
Indicator Compounds
Ideally, toxicity should play a major role in
the selection of indicator compounds.
Unfortunately, little is currently known
about acute and chronic toxicity of
individual congeners to mammals. Occur-
rence determines, in combination with toxi-
city, whether a compound is important.
Stereochemistry may play an important role
since the biologic disposition of enantiomers
varies (125) (Table 7). Boon et al. (128)
showed that B[12012]-(202) and B[12012]-(212) did not yield a positive response in a
mutatox test, whereas technical toxaphene
and B[30012]-(1 1 1) did yield a positive
response. The latter compound is onlydetected in low concentrations in wildlife
samples (69,99,117).
Next to these parameters, analytic
convenience is important. The compounds
should be detectable without the interfer-
ence of other compounds when common
extraction, clean-up, and separation/detec-
tion procedures are used. The compounds
should also be commercially available (92).
In practice, the availability of standards
and analytic convenience dictate the
choice of compounds, a situation similar
to that with PCBs. The concentrations of
B[12012]-(202), B[12012]-(202), and
B[30030]-(122) are in the 0.05 to 0.08 mgkg-1 (fat basis) range in fish and other
foodstuffs and their peaks represent about
50% of the total toxaphene ECD response.
Because it is presumed that these congeners
are also dominant in human toxapheneintake, Alder and Vieth (92) suggested
their use as indicator compounds. To dis-
tinguish between recent contamination
(e.g., recent use of the pesticide) and per-
sistent congeners still present in the envi-
ronment, an indicator compound that is
not stable in the environment can be con-
cluded. B[30012]-(1 11) was suggested for
this purpose (92). Xu et al. (119) proposed
a second compound, B[30032]-(122), for
the same purpose. Because this compound
was found to degrade easily in the detector
and is only present in minor amounts in
technical formulations, it is not useful as
an indicator compound (92). Measuring
the individual indicator compounds on a
single GC column presents a problem in
that several compounds may be present in
one peak, as demonstrated by heart-cut
multidimensional GC (69).
Instead of measuring the toxaphene
compounds in all fish for consumption,
samples from important species and fishing
areas can be selected to answer the question
of human intake of these compounds, as
was done in a large study by Alder et al.(100). As an alternative, Alder and Vieth(92) chose to mix edible parts of relevant
fish samples (97), before extraction and
residue analysis. The fish samples, however,
were not prepared in the way they are
generally consumed.
Levels in Biota
Totl Tophene
Most of the available information about
toxaphene concentrations in biota is
referred to in terms of total toxaphene.
However, since the number and pattern of
congeners in environmental samples is sub-
stantially different from those in the tech-
nical mixture (as a result of environmental
and metabolic modification) (88,113), val-
ues for total toxaphene should be consid-
ered only indicative. Table 8 gives an
overview of the total toxaphene levels inbiota samples as reported in the literature.
Much of the information about total
toxaphene levels in biota described in the
literature is from studies of freshwater sys-
tems in Canada and the United States,
where toxaphene was one of the most
dominant organochlorine residues (161).
Toxaphene concentrations plateaued after
a period of steady increase through the1970s, but its incidence continued to
increase; residues were present at 88% of
the stations sampled from 1980 to 1981(162). From 1978 to 1979, toxaphene
concentrations were highest in lake trout(Salvelinus namaycush) samples from Lakes
Michigan and Superior, with typical con-
centrations of 5 to 10 pg g-' lipid (163).
From 1980 to 1981, concentrations were
generally lower, 2 to 5 pg g-1 lipid. Con-
centrations of toxaphene declined in trout
and smelt from the Great Lakes between
1982 and 1992 except for fish from Lake
Superior (159).
Little toxaphene has been used in the
Great Lakes basin alone. The main input is
thought to be through atmospheric trans-
port from the southern United States or
Central America, followed by wet and drydeposition (53,115). Atmospheric trans-
port was probably also responsible for
residues detected in fish from lakes in
Alaska. Several other reports conclude that
toxaphene is carried in the atmospherefrom the site of application and its accu-
mulation is widespread in freshwater and
marine fish (90).
Geographic variation in toxaphene
and other organochlorine pesticides
within the Canadian Arctic has been
examined in several studies. In Arctic char(Salvelinus alpinus) residues of toxaphenegenerally increased from west to east, with
generally higher levels in samples from
Baffin Island and Hudson Bay (164). The
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Table 8. Total toxaphene in biota.
Total toxaphene, Total toxaphene,
Species Location Year Tissue n Sex pg/g ww pg/g lipid Reference
Marine invertebrates
Zooplankton Ice Island
81 ON, 010 W
Zooplankton 64N,169W
Benthic amphipods Ice Island
(Anoxy sarsi and 810N,1010 'A
Tmetonyx cicada)
Scallops Georges Bank
(Placopecten magellanicus)
Blue mussel (Mytilus edulis) Greenland
Marine fish
Arctic cod
(Boreogadus saida)
Arctic Bay
Resolute Bay
Pangnirtung
1986
1987
1988
1986
1987
Arctic cod Greenland
Antarctic cod South Georgia
(Dissostichus eleginoides)
Atlantic cod (Gadus morhua) Gulf St. Lawrence
Atlantic cod Gulf of Finland
Vester Tana
Atlantic cod Southern North Sea
Central North Sea
Northern North Sea
Atlantic cod Germany
Atlantic cod
Atlantic cod North Sea
Atlantic salmon (Salmo salar) Alaska
Galway, Ireland
Atlantic salmon W. Greenland
Labrador Sea
Atlantic salmon Teno R., Arctic
Simo R., Bothnian Bay
Bothnian Sea
Baltic Proper
L. Saimaa
Atlantic salmon Norway
Norway
Greenland cod (Gadus ogac) Frobisher Bay
Victoria Island
Hake (Merluccius merluccius) Ireland
Herring (Clupea harengus) Baltic
Herring Gulf St. Lawrence
Halifax
Herring Southern North Sea
Herring Skagerrak
lnconnu (Stenodus leucichthys) Tuktoyaktuk Harbour
Pacific herring Tuktoyaktuk Harbour
(Clupea havengus)
Plaice (Pleuronectes platessa) German Bight
Skagerrak
Pollack (Gadus pollachius) Bering
Shorthorn sculpins Greenland
(Myoxocephalus scorpius)
Sturgeon (Acispencer stellatus) Caspian Sea
Trout (Salmo trutta) Bothnian Bay
Bothnian Sea
Twait shad (Alosa fallax) North Sea
Marine mammals
Beluga whale
(Delphinapterus leucas)
S. Beaufort Sea
Jones Sound
Whole Pool
Whole Pool
Whole Pool
Whole Pool
Whole Pool
1979 Muscle Pool
1994-1995 Muscle Pool
1984 Muscle Pool
1984 Muscle Pool
1984 Muscle Pool
1994-1995 Liver Pool
1977 Liver 1
1979
1988
1989
1989
1989
1989
1993)
1993)
7
1979
1979
1979
1979
1988
1990
1988
1991
1988
1988
1988
1993)
1993)
1984
1984
?
1978
1979
1979
1989
1
1984
1984
Liver Pool
Pool
Pool
Liver Pool
Liver Pool
Liver Pool
Liver oil Pool
Liver oil Pool
Liver Pool
Spawn 1
Spawn 1
Whole 2
Whole 2
Muscle Pool
Muscle Pool
Muscle Pool
Muscle Pool
Muscle Pool
Muscle Pool
Muscle Pool
Oil Pool
Oil Pool
Whole 2
Muscle Pool
Liver
Muscle Pool
Muscle Pool
Muscle Pool
Muscle Pool
Muscle Pool
Muscle 1
Muscle Pool
1989 Liver Pool
1989 Muscle Pool
1988 ? ?
1994-1995 Liver Pool
1978-1979 Spawn Pool
1990-1991 Muscle Pool
1990-1991 Muscle Pool
? Muscle Pool
1983-1987 Blubber 10
2
1984 8
7
m
F
m
F
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0.024
0.16
(2)
(144)
(2)1.5
8.3
(84)
(145)
(146)
(145)
(4)0.68
2.4
0.64
0.54
0.4
0.6
l
2.45
2.73
0.285
3.5
(84)
(49)
(102)
(147)
(4)
(148)
(49)
0.002
ND
ND
0.023
0.014
0.046
ND
0.22
1.1
0.3
0.041
0.26
0.3
0.084
0.006
<0.002
0.9
0.4
0.04
0.024
0.074
0.013
ND
0.304
2.87
0.89
2.58
0.91
2.01
0.78
6.99
1.1
0.54
13
12
4.4
0.4
(102)
(146)
(147)
(149)
(84)
(89)
(147)
(146)
(146)
0.2
0.1
(89)
(144)
(145)
1.625
1.12
0.52
0.02
(4)
(49)
(147)
3.83±1.16
1.38
4.25 ± 1.02
3.74 ± 2.12
(150)
(Continued)
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Table 8. Continued.
Species Location
Beluga whale
Narwhal
(Monodon monoceros)
White-beaked dolphin
(Lagenorhynchus albirostris)
White-beaked dolphin
Pilot whale
(Globicephala melaena)
Walrus (Odobenus
rosmarus divergens)
Grey seal
(Halichoerus gryphus)
Harbor seal (Phoca vitulina)
Ringed seal (Phoca hispida)
Freshwater fish
Arctic char
(Salvelinus alpinus)
Arctic char
Arctic char
Burbot (Lota Iota)
Burbot
Carp
Eel (Anguilla anguilla)
Guapote (Cichlasoma
managuense)
Lake trout
(Salvelinus namaycush)
Lake trout
Lake trout
Lake trout
Pike (Esox lucius)
Rainbow trout
(Salmo gairdnerii)
Rainbow smelt
(Osmerus mordax)
Sculpin(Comephorus dybowskii)
Tilapia (Sarotherodos
mossambicus)
W. Hudson Bay
Cumberland Sound
Alaska
W. Baffin Bay
Newfoundland
North Sea
Newfoundland
N. Bering Sea
Baltic
Skagerrak
Baltic
Greenland
Drachensee
W. Davies Strait
Greenland
L625 ELA
Lake Winnipeg
Trout Lake
South Indian Lake
Mackenzie River, Ft. Simpson
Mackenzie River, Ft. Good Hope
Mackenzie River, Arctic Red River
Mackenzie River, Ft. McPherson
Yukon River, Laberge Lake
Yukon River, Kluane Lake
Saginaw Bay
River Rhine
Lake Yssel
Lake Xolotlan, Monotombo
Lake Michigan
Lake Michigan
Lake Superior
Lake Huron
Lake Ontario
Yukon River, Laberge Lake (?)
Yukon River, Watson Lake (?)
Siskiwit
Lake Carigellen
Peanut Lake
Chatwin Lake
Lake Superior
Lake Michigan
Lake Ontario
Lake Baikal
Lake Xolotlan, Monotombo
Year
1986
1983
1992
1982-1983
1980-1982
1980-1982
1981-1984
1974-1977
1988
1988
1994-1995
1978
1985
1994-1995
1985-1986
1985-1986
1985-1986
1985-1986
1985-1986
1985-1986
1985-1986
1985-1986
1990-1992
1990-1 992
1989
1989
1991
1982
1982
1992-1994
1982
1992-1 994
1982
1992-1994
1982
1992-1994
1990-1992
1990-1992
1979
1993
1993
1982
1992-1994
1982
1992-1 994
1982
1992-1994
1990
1991
Total toxaphene, Total toxaphene,
Tissue n Sex pg/g ww pg/g lipid Reference
Blubber
Blubber
Blubber
Blubber
Blubber
Blubber
Blubber
Blubber
Blubber
Blubber
Spawn
Whole
Muscle
liver
Liver
Liver
liver
Liver
Liver
Liver
Liver
Liver
Liver
Muscle
Muscle
Muscle
Belly
Whole
Whole
Whole
Whole
Whole
Whole
Whole
Whole
Muscle
Muscle
Whole
Spawn
Muscle
Muscle
Whole
Whole
Whole
Whole
Whole
Whole
Whole
Muscle
4
4
6
6
7
15
6
9
13
1(?)
5
9
53
Pool
Pool
Pool
Pool
6
Pool
12
14
7
14
5
8
4
4
Pool
Pool
Pool
Pool
Pool
19
4
Pool
Pool
Pool
Pool
Pool
Pool
Pool
Pool
Pool
Pool
Pool
3
3
3
Pool
Pool
Pool
Pool
Pool
Pool
Pool
14
m
F
m
F
m
F
M
F
m
F
M&F
5.10 ± 0.42
1.77 ± 1.41
5.78 ± 5.39
1.77 ± 1.76
9.16 ± 2.35
2.44 ± 2.84
46.0±22.1
38.2 ± 10.7
19
11.7 ± 7.05
2.22 ± 2.29
<0.1
0.26
0.017
0.157±0.067
0.013
1.57
1.7
0.93
2.81
54
0.51
0.051
4.3±3.7
5
1.5
4.9
6.7
5.2
2.4
4.5
0.54
0.657
<0.01
0.29
0.03
0.008
0.068
0.41
0.16
0.74
0.059
0.72
0.067
5.18 ± 4.77
83.6 ± 75.4
53.3 ± 11.7
16.0 ± 9.73
3.41 ± 3.26
11
0.35
1.5
0.125
1.73
0.807
2.34
1.47
1.13
0.3
0.09
27
7.6
28
35
30
13
24
2.8
0.24
0.71
1.04
10
3.1
10
1.1
11
1.1
1.-62.1
0.04
(151)
(94)
(152)
(147)
(153)
1149)
(72)
(145)
(4)
(154)
(145)
(155)
(156)
(115)
(89)
(157)
(158)
(159)
(156)
(115)
(4)
(160)
(159)
(26)
(157)
(Continued)
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Table 8. Continued.
Total toxaphene, Total toxaphene,
Species Location Year Tissue n Sex pg/g ww pg/g lipid Reference
Walleye (Stizostedion Lake Erie 1982 Whole Pool 0.25 2.2 (159)
vitreum vitreum) 1992-1994 Whole Pool 0.13 1.4
White fish Lake Baikal 1991 Whole 2 0.93-1.3 (26)
(Corogunus autumnalis)
White fish Yukon River, Laberge Lake 1990-1992 Muscle Pool 0.04 (156)
(Corogunus clupeaformis) Yukon River, Watson Lake 1990-1992 Muscle Pool <0.01
White fish Siskiwit ? ? Pool 0.22 (115)
Abbreviations: M, male; F, female; ?, unknown.
results for Arctic char are consistent with
the movement of organochlorines in air
masses from South/Central America in a
northeasterly direction. As northern lati-
tude increases, concentrations of several
organochlorines were also found to
decrease for burbot (Lota lota) (155).
Toxaphene was the predominant organo-
chlorine residue in northern fish samples.
The peak pattern of toxaphene in the chro-
matograms showed extensive transforma-
tion compared to technical toxaphene
mixtures. Levels of toxaphene were not sig-
nificantly correlated with age or weight of
the fish. Kidd et al. (156) studied the spa-
tial variability of toxaphene in fish col-
lected between 1990 and 1992 from lakes
in the Yukon Territory and found that the
levels varied considerably between lakes
probably because of differences in the food
chains of the lakes.
Toxaphene was also the major
organochlorine residue in Canadian Arctic
marine invertebrates and fish. Arctic cod
(Boreogadus saida) in three eastern Arctic
locations had concentrations of toxaphene
5- to 10-fold higher than those for DDT or
PCB (146). Musial and Uthe (84) found
that levels of CHBs in Arctic cod liver were
about 2-fold lower than those in Atlantic
cod (Gadus morhua). Bidleman et al. (2)
reported levels of toxaphene to be equiva-
lent to those of PCBs in zooplankton and
in amphipodes collected from an ice island
in the Arctic Ocean. Other organochlorines
had lower concentrations. Toxaphene was
found to be a major contaminant in
Atlantic cod liver and herring (Clupea
harengus) muscle from eastern Canadian
waters, with levels similar (lipid weight
basis) to those for PCB but generally higher
than those for DDT (84). Toxaphene was
not detected in deep-sea (Canadian waters)
scallop (Placopecten magellianicus) (84).
High levels of toxaphene were reported
for white-beaked dolphins (Lagenorhynchus
albirostris) and pilot whales (Globicephala
malaene) collected from 1980 to 1982
from the coast of Newfoundland (152).
This was explained by the increased use of
toxaphene during the 1970s. Toxaphene
levels were higher than those for other
organochlorines such as PCBs and DDT
Most of the peaks in the toxaphene stan-
dard were not present in dolphin blubber,
an indication of the dolphin's considerable
metabolism and/or selective accumulation
of some isomers and/or metabolites. Two
peaks accounted for about 50% of the
toxaphene peaks (probably GC-EI/MS).
Toxaphene also was the major organochlo-
rine contaminant detected in blubber of
Arctic belugas (Delphinapterus leucas)
(150). Little geographic variation in the
concentration of toxaphene was observed
in five different areas (East Hudson Bay,
Cumberland Sound, West Hudson Bay,
Beaufort Sea, and Jones Sound). Geo-
graphic comparisons of toxaphene levels
for belugas are difficult because belugas
migrate over relatively long distances and
spend most of the year at the ice edge
rather than at the locations where they
were sampled. Belugas collected from the
north coast ofAlaska had higher toxaphene
concentrations in blubber (151) than
PCBs, DDTs, and chlordanes in the same
samples. Males had higher concentrations
of toxaphene than females and the oldest
male had a higher concentration than the
youngest male. Transplacental transfer to
the fetus and through lactation to the nurs-
ing pups are the most probable causes of
the lower toxaphene levels in females com-
pared to males. Stern et al. (165) identified
the two major recalcitrant toxaphene con-
geners in aquatic biota from beluga blubber
as B[12012]-(202) and B[12012]-(212).
Their sum constituted 28 to 34% of total
toxaphene in arctic char, 53% in burbot,
and 81 to 89% in beluga whale blubber
from the Canadian Arctic.
Toxaphenes were the dominating
organochlorines in narwals (Monodon
monoseros) collected from 1982 to 1983
from northern Baffin Island in the
Canadian Arctic (94) and was composed
of two major components, an octachloro-
borane and a nonachlorobornane. The pat-
tern of organochlorines in tissue suggests
that narwals are exposed proportionally to
more volatile compounds and may be less
able to metabolize some of these com-
pounds than odontocetes living closer to
sources of these contaminants.
Toxaphene was measured in land-
locked Arctic char and ringed seal (Phoca
hispida) from Greenland (145). Char
from the east coast of Greenland had
toxaphene levels that were significantly
higher than those in char from areas of the
west coast. However, overall levels of
toxaphene in muscle were low. Seals dis-
played no significant geographic variation
in toxaphene levels, presumably because of
their relatively high biotransformation
capacity for toxaphene (128).
Zell and Ballschmiter (4) analyzed fish
from different regions to characterize
organohalogens in pristine aquatic environ-
ments. They found toxaphene in spawn of
Arctic char (S. alpinus) from a lake in the
Tyrolean Alps, pike (Esox lucius) from
northwest Ireland, sturgeon (Acispenser
stellatus) from the Caspian Sea, salmon
(Salmo salar) from Ireland and Alaska, and
in the livers of Antarctic cod (Dissostichus
eleginoides) from South Georgia. They
indicated that the global pollution by
toxaphene could be as widespread or more
so than compounds like those in the DDT
and PCB groups. The pattern of toxaphene
spread was modified to a variable extent
compared to that of technical mixtures.
Samples from the North Atlantic Ocean
and the Caspian Sea contained levels about
10-fold higher than those from samples of
other areas.
Few investigations of toxaphene in
biota have been carried out in the lakes of
Asia. Kucklick et al. (26) studied organo-
chlorines in the food chain of Lake Baikal
in central Siberia. Baikal seals (Phoca
siberica) occupy the top trophic level,
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feeding primarily on the endemic white-
fish or omul (Coregonus autumnalis) and
planktivorous sculpin (Comephorus
dybowskii). Toxaphene in biota ranged from
1.1 to 2.3 pg g-' lipid in sculpin and seal,
respectively, indicating little biomagnifica-
tion of toxaphene from fish to seal.
Toxaphene patterns in seals were degraded
to a greater extent than those in fish but
retained several prominent congeners. These
results are in agreement with degradation
studies by Boon et al. (128).
Levels of toxaphene and other
organochlorine pesticides have been ana-
lyzed in tilapia (Sarotherodon mossambicus)
and guapote (Cichlasoma managuense) col-
lected in 1991 from Lake Xolotlan in
Nicaragua (157). The carnivorous tilapia
contained concentrations of toxaphene 4
to 5 times that in the omnivorous guapote.
Located on the shore of the lake was a fac-
tory producing toxaphene, which may
have contributed to some of the high levels
of toxaphene.
Jansson et al. (149) reported total
toxaphene residues in Arctic Char (S.
fontinalis) from lake Vattern in southern
Sweden, and in grey seal (Halichoerus gry-
phus) and herring (C. harengus) from the
Baltic Sea. Fish from the different areas
gave similar chromatograms, indicating
widespread input of toxaphene to the
whole region through the atmosphere.
This finding was supported by Paasivirta
and Rantio (166), who compared toxa-
phene levels in salmon from the Arctic and
the Baltic and found no significant differ-
ence. Similarly, levels of toxaphene in cod
liver did not differ. Toxaphene has not
been used as a pesticide in Scandinavia.
Andersson and Wartanian (72) analyzed
toxaphene in blubber samples from various
seal species collected from the Baltic and
the west coast of Sweden. Toxaphene levels
in Baltic seals were higher than those in
animals from the west coast of Sweden.
Comparison of the data for adult and juve-
nile seals revealed, in addition, to age-
related variation in contamination, i.e.,
toxaphene levels in adult Baltic ringed seals
were significantly higher than those in
adult grey seals from the same region and 5
to 10 times than those in juvenile ringed
seals from the same region. Andersson
et al. (148) reported no geographic differ-
ences in concentrations of toxaphene from
animals in the Arctic region with those in
corresponding species in the Baltic.
Several reports on levels of toxaphene in
fish and fish products from Europe show
the ubiquitous presence of toxaphene in all
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types of fish (89,167,168). High residues of
toxaphene in fish and fish products from
Europe were reported by Muller et al.(167), who showed that toxaphene concen-
trations in herring and mackerel (Scomber
scombrus) from the North Sea and the rela-
tively remote waters west and northwest
and of Ireland and the Shetland Islands
exceeded the German tolerance level, which
was 0.1 mg kg-l on a lipid basis or 0.01 mgkg-l wet weight (ww) at that time. van der
Valk and Wester (89) conducted a study in
fish from northern Europe. Highest
toxaphene concentrations were found in
herring oil from the Baltic (7 pg g-' lipid).
Toxaphene levels in cod liver showed an
upward trend from the southern to the
northern North Sea, increasing from 0.4 to
1 jig g-' lipid. This finding was somewhat
unexpected, as the northern North Sea usu-
ally is considered less polluted than the
southern North Sea. de Boer and Wester
(7) report that toxaphene has almost never
been used in Western Europe. Accum-
ulation of toxaphene in northeastern
Atlantic waters may be attributable to aerial
transport from the American continent.
The authors also reported that Baltic her-
ring oil probably contained high toxaphene
concentrations because of continued use of
toxaphene in East European countries.
Concentrations of Individual
Congeners
Gooch and Matsumura (158) suggested
that since environmentally derived toxa-
phene is extensively altered compared to the
technical material, measuring only the toxic
congeners would be environmentally rele-
vant. They reported mean levels of Toxicant
A [a mixture of B[30030]-(211) and
B [30030]-(121)] and B [30012] -(1 1 1) in
fish from Lake Michigan were 0.26 and 0.1
pg g-1 ww, respectively, approximately one
order of magnitude less than the estimated
concentration of total toxaphene.
Hainzl et al. (88) analyzed individual
toxaphene compounds in fish and caviar
from several European countries. B[30012]-(111), B[12012]-(212), and B[30030]-(122) were the most prominent com-
pounds, whereas concentrations of
B[12012]-(202) and B[30032]-(122) were
below detection levels or very low (< 0.1
ng g-') in all samples analyzed (Table 9).
Icelandic cod liver contained the highest
concentrations (Table 9). Toxaphene in
the livers of hake from west of Ireland and
herring muscle and dolphin blubber from
the North Sea were all studied by de Boer
et al. (170), who found B[12012]-(202)
and B[12012]-(212) to be dominant
compounds, whereas B[30012]-(111) was
not detected in most samples.
Alawi et al. (102), using different
analytical techniques, analyzed B [300121-(111), B[12012]-(212), B[30030]-(122),
B[12012]-(202), and B[30032]- (122)
in samples of marine fish. The fish
and fish products were obtained from
Iceland, Greenland, Japan, Norway, and
Germany. The compounds B[12012]-(202),
B[12012]-(212), and B[30030]-(122) were
present in most of the fish samples (espe-
cially those from the North Atlantic) in
concentrations similar to those for impor-
tant PCB congeners and cyclodiene. These
three chlorinated bornanes constituted the
major portion of the toxaphene residues in
cod liver oil (25-30%). In fresh fish and
caviar these substances amount to approxi-
mately 8 to 12% of total toxaphene.
B[30012]-(1 11) was found in only a few
samples and at very low concentrations.
B[30032]-(122) was below detection levels
in all samples analyzed. Cod liver oil and
salmon oil from the North Atlantic con-
tained higher levels of toxaphene than red
fish and halibut (Table 9).
Alder et al. (100,136) analyzed threeindicator compounds, B[12012]-(202),
B[12012]-(212), and B[30030]-(122), in
different samples of fish from the North
Atlantic Ocean, North Sea, Baltic Sea, and
a few other locations (Table 9). Highest
residue concentrations were found in
marine fish with moderate-to-high fat con-
tent such as halibut, herring, redfish, and
mackerel. The sum of the indicator com-
pounds in sardines and in fish with lean
muscle tissue levels (Alaska pollock, saithe,hake, and cod) were low. Farmed salmon
from Chile showed lower levels of the
three compounds than salmon from the
northern hemisphere. Eel from the Baltic
contained relatively low levels. Fromberg et
al. (171) determined the three indicator
compounds in several fish samples from
Danish waters. Their concentrations rangedfrom approximately 5 to 50 ng g`1 fat and
are in agreement with previously reported
results for mackerel, eel, salmon, and her-
ring from Skagerak; however, these con-
centrations are 3 to 8 times that of those
reported for herring from the Baltic Sea(100). Fish, especially herring, are not sta-
tionary, so these differences could be
attributable to migration.
Condusion
The literature shows that toxaphene has aglobal distribution and can be found in
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Table 9. Amounts of individual chlorinated bornane congeners in biota.
Sample/species
Arctic char,
whole fish
Location
North Quebec (Ungava)
Pollock muscle Northwest Pacific
Arctic Sea
Caviar substitute Iceland
Germany
Cod liver oil Germany
Cod muscle Greenland
Cod muscle Iceland
Cod liver Barents Sea
Eel muscle France
Spain
Germany
Italy
Eel muscle Baltic Sea
Hake Southeast Pacific
Halibut muscle Iceland
Norway, west coast
Halibut muscle Germany
Hake liver Atlantic Ocean
Herring muscle North Sea
Herring muscle Baltic Sea
Ireland
English Channel
North Sea, Fladen Ground
North Sea, Skagerrak
North Sea, Bressay Ground
West of British Isles
Norway, west coast
Canada, east coast
West of Shetland
Mackerel muscle West of Shetland
North of Shetland
North Sea
Plaice muscle North Sea
Polar cod liver Barents Sea
Red fish muscle Greenland
Redfish muscle Iceland
Norway
Saithe muscle Iceland
North Sea
Salmon oil Norway
Norway
Iceland
Ireland
Scotland
Chile
Sardine Bay of Biscay
Trout muscle Germany
B[1 201 21-1202),
ng g1 ww
44-74
0.1
ND
24-58
14-33
100-245
30-50
ND
19-70
<0.1-0.2
ND
ND-0.2
ND
1.8-2.8
ND
5.4-23.4
5.4-11.8
2-5
30-100
<1-2
2.9-5.7
1.6-2.6
1.5-4.3
1.1-4.2
ND-1.5
7.1-13.9
4.3
4.7-6.8
1.2-2.6
5.8
2.5-5.6
1.7
ND-2.5
ND
23
2-9
1.2-6.9
1.2-2.5
0.4
0.1-0.2
7-28
2.8-8.0
6.5
1.6
2.4
0.6
0.2-1.1
0.5-1.2
B[1201 21-(21 2),
ng g-1 ww
83-138
0.1
0.1
33-110
18-94
140-550
35-145
0.1
37-122
19-20
18-19
10
7.9-8.5
ND-3.7
0.1
10.0-27.8
9.4-19.6
8-34
7-30
1-3
3.4-7.2
3.4-5.0
3.3-8.4
1.5-8.0
1.0-2.0
4.1-4.2
8.4
8.2-16.0
1.4-3.2
12.0
3.0-6.0
3.4
2.3-5.0
ND
50
8-34
2.3-9.7
2.2-4.9
0.5
0.2-0.5
20-105
3.5-13.4
9.0
3.0
6.3
0.9
0.4-1.9
0.7-2.1
Bl30030]-(1 22),
ng g- ww
ND
ND
7-33
5-18
75-171
14-58
ND
11-51
5.7-6.4
1.3-1.7
3.7
0.45-0.60
ND-2.8
ND
8.4-29.2
7.2-13.3
12-98
<1-1
<1-2
1.6-4.3
1.6-3.8
2.1-6.3
ND-5.5
ND
8.7-10.2
6.5
6.4-10.8
1.0-2.0
9.3
1.9-3.0
3.6
ND-3.9
ND
26
1-17
2.2-15.2
1.7-3.8
0.2
0.1
1-27
2.4-8.2
6.5
1.8
4.9
ND
ND-0.8
ND-1.5
ND, not determined.
both fresh water and marine biota all over
the world. Also, at remote areas long
distances from toxaphene sources, the lev-
els in biota can be quite high. These find-
ings illustrate the importance of long-range
transport, perhaps through the atmos-
phere, in the global spreading of this
group of contaminants.
Toxicology
Since the late 1940s, reports have been
published addressing the toxicity of the
chlorinated camphenes to fish, bi
mammals (172-176). In ac
toxaphene was found to elicit m
and carcinogenic properties in ma
test systems, thereby posing a t
humans (25,177).
Toxicokindtcs and Biotansfori
The use of toxaphene as a pisci
discontinued after the discovo
toxaphene was persistent in the
environment and its presence pi
successful restocking of treated lakes with
desirable fish (178,179). However, experi-
Reference mental information is scarce on the depu-
ration of toxaphene in fish and their
(165) residue kinetics. Delorme et al. (180) stud-
(100) ied the elimination rate of toxaphene and
two of the more persistent congeners,
(102) B[12012]-(202) and B[12012]-(212), in
lake trout and white suckers in a natural
ecosystem following intraperitoneal injec-
tion of technical toxaphene (7 pg g-' for
(169) white suckers; 3.5 and 7 pg g-1 for lake
(119) trout). The estimated half-lives for total
toxaphene were 524 days for white suckers
and 232 (high dose) and 322 (low dose)
days for lake trout. Half-lives for the two
( 100) congeners in trout were 294 and 376 days
(high dose) and 316 and 367 days (low
dose), respectively. In white suckers, only
(102) B[12012]-(202) was detected and its half-
(170) life was 716 days. On the basis of these
results, the authors concluded that under
(100) natural living conditions these species dif-
fer in elimination rates of toxaphene and
that elimination of two different chloro-
bornane components of toxaphene,
B[12012]-(202) and B[12012]-(212), is
different within a given species.
Mohammed et al. (181) studied the
role of plasma lipoprotein in the transport
and tissue accumulation of toxaphene. 14C-
Radiolabeled toxaphene in the absence or
presence of either low-density lipoproteins
(LDL) or high-density lipoproteins (HDL)(169) was injected intravenously into normo-
(100) and hypolipidemic mice. In normolipi-demic mice, most of the radioactivity ini-
tially was found in the liver and adrenals
either in the absence or presence ofLDL or
(102) HDL. Four hours after application, the
(100) radioactivity was redistributed into the adi-
pose tissue. Notably, lower amounts of
radioactivity were found 20 min after mice
were injected with toxaphene in combina-
tion with HDL than in mice injected with
14C-toxaphene-LDL, suggesting a more
efficient metabolism and disposal of toxa-
phene when HDL was used as a carrier.
Mohammed and co-workers initially found
irds, and less 14C-radiolabeled toxaphene in the liver
Idition, and adrenals and more in the kidney and
utagenic heart of hypolipidemic mice (181). 14C-
mmalian Toxaphene was redistributed mainly to the
hreat to liver and only in small amounts to adipose
tissue 4 hr after injection. According to the
authors, these results indicate that changes
onatlOl in the lipid pattern may influence tissue
cide was distribution of toxaphene. Mohammed
ery that et al. (181) also studied the distribution of
aquatic 14C-radiolabeled toxaphene among lipo-
revented protein fractions in vitro and in vivo using
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human and rat plasma. In rat 37 to 52% of
radioactivity was recovered in the HDL
fraction, whereas 18 to 52% was associated
with the albumin-rich bottom fraction(BF) both in vivo and in vitro. In contrast
to distribution in the rat, the in vitro distri-
bution of 14C-toxaphene among human
lipoprotein fractions is relatively homo-
geneous. In the BF, 26% of radioactivity
was found, whereas in the HDL, LDL, and
very low-density lipoproteins (VLDL) frac-
tions, 27, 29, and 18% of radioactivity
were recovered, respectively.
Reductive dechlorination or dehydro-
chlorination and, in some cases, oxidation,
have been shown to be the major mecha-
nisms by which toxaphene is metabolized in
microorganisms as well as in insects, birds,
aquatic organisms, and mammals (1,182).
Degradation of toxaphene in the soil pro-
ceeds rather slowly under aerobic condi-
tions, whereas under anaerobic conditions
toxaphene is more easily degraded (139).
Fingerling et al. (36) investigated the
degradation under anaerobic conditions of
six polychlorinated bornanes, B [30012]-
(111), B[30012]-(211), B[30012]-(121),
B[30012]-(112), B[30012]-(212), and
B[30012]-(122), isolated from technical
toxaphene as well as the technical mixture
in a loamy silt. All individual bornanes
were transformed by reductive dechlorina-
tion, usually starting with the removal of
a chlorine atom from the geminal
dichlorogroup in the C-2 position. The
dechlorination rate depends on the chlori-
nation stage (nonachlorobornanes> octa-
chlorobornanes > heptachlorobornanes).
Two stable end metabolites formed from
all six bornanes were isolated and identi-
fied as B[21002]-(111) and B[21001]-(1 1 1). Interestingly, the major degradation
product of technical toxaphene was shown
to be B[20012]-(111), one of the two
end-metabolites of the six bornanes
tested. In addition, Fingerling et al. (36)
showed that none of the components
tested were degraded in autoclaved soil,
indicating that degradation is mediated
primarily by microorganisms.
In contrast to the identification of
dechlorination products formed from
toxaphene components as well as technical
toxaphene under anaerobic conditions in
soil, reports on the isolation and characteri-
zation of oxygen-containing products is
scarce. Fingerling and Parlar (183) for the
first time isolated and characterized under
anaerobic conditions an oxygen-containing
product as a conversion product of the
toxaphene components B[30012]-(21 1),
B[30012]-(121), and B[30012]-(111). This
cyclo ketone (7b,8c,9c-trichlorocamphene-
2-one) probably is not formed from one of
the two main hexachlorobornane products(36); possibly it is formed from the dehy-drochlorination product B[21001]-(1 1 1),
which is formed as a small byproduct of
B[30012]-(111), B[30012]-(211), and
B[30012]-(121).
According to Saleh (1), hepatic micro-
somal mixed-function oxidases are most
important in toxaphene metabolism in
mammals, followed by glutathione
S-transferases. Chandra and Durairaj (184)
showed that in addition to inducing
cytochrome P450 and aniline hydroxylase
activity in the liver, toxaphene also induces
activity of these enzymes in the kidney.
Therefore, the authors speculate that
toxaphene alone may be metabolized in the
liver as well as in the kidney.
In an attempt to evaluate the role of
phase I biotransformation in the bioaccu-
mulation process of toxaphene, Boon et al.(128) demonstrated in vitro metabolism of
toxaphene using hepatic microsomes from
harbor seal, whitebeaked dolphin, harbor
porpoise, and albatross sampled shortly
after death. In addition to toxaphene, the
in vitro metabolism of four individual
chlorobornane congeners was tested.
B[12012]-(202) and B[12012]-(212) were
persistent in all assays, whereas B[30012]-(1 1 1) was metabolized by hepatic micro-
somes isolated from the four wildlife
species. It was also found that harbor seal
hepatic microsomes only metabolized
B [30030] -(122). Neither toxaphene nor
the four congeners were metabolized in
vitro using hepatic microsomes of the
sperm whale. Interestingly, the authors'
results showed that the in vitro capacity of
microsomes derived from the different
species to metabolize technical toxaphene,
reflects the decreasing number of peaks in
the toxaphene residues of wildlife extracts.
Aquatic Toxicity
Toxaphene is highly toxic to aquatic organ-isms. It was found that in general saltwater
fish are more sensitive to toxaphene thenfreshwater fish (mean acute toxicity values
of 0.07 pg liter-i and 1.6 pg liter-1, respec-tively) (1). Keller (185) studied the acute
toxicity of several pesticides, includingtoxaphene in freshwater mussels (Anodontaimbecilis), and compared their sensitivities
to those in common test organisms such as
Daphnia magna, Cerio dubia, and fathead
minnow (Pimephales promelas). The 96-hr
LC50 for A. imbecilis exposed to toxaphene
was 0.74 mg liter- . Compared to the
other organisms tested, A. imbecilis is less
sensitive to toxaphene. The acute toxicitylevels for toxaphene in most aquatic organ-isms range from 1 to 40 pg liter-1 (1).
Interestingly, addition of sediment to the
test chambers drastically reduced the toxic-ity of toxaphene to A. imbecilis. Thus, sus-
ceptibility of A. imbecilis to toxaphene
toxicity appeared to vary depending on
whether concentrations were sediment- or
aqueous-bound.
Application of toxaphene to lakes as a
piscicide has caused direct as well as indirect
damage to the ecosystem. Direct damageincludes disappearance of target as well as
nontarget organisms inhabiting toxaphene-
exposed waters. Indirect damage occurred
when application of toxaphene resulted in
some cases in replacement of native organ-isms by a new population of organisms,
which modified the structure of the ecosys-
tem. Miskimmin and Schindler (186)
examined the response to toxaphene appli-
cation and stocking with a nonnative fish
species on total chironomids, Chaoborus
spp., planktonic Cladocera in a meso-
trophic lake (Peanut Lake, north basin),
and a eutrophic lake (Chatwin Lake) in
central Alberta, Canada. The response in
these lakes was compared to that in a lake
that had not been treated (Peanut Lake,
south basin). The authors studied some
invertebrates prior to application of
toxaphene during 1961 to 1962 and
examined recovery of the community inthe following 30 years by analyzing sedi-
ment cores from the lakes. They foundthat as a result of toxaphene application(0.0184 ppm) to Chatwin Lake, plank-
tonic Cladocreans decreased in abundance
and dominance changed from small- tolarge-body types. No short-term effects
were detected by examining sediment coresfrom the toxaphene-treated Peanut Lake(0.0075 ppm). In the absence of native fish
and during trout stocking, large inverte-brates became dominant in both treated
lakes. Residual toxicity and/or predation by
stocked fish in both lakes probably resultedin low population levels of Chaoborus spp.throughout the 1960s. Long-term changesin invertebrates in both lakes probably were
a result of the manipulation of fish commu-
nities rather than effects of residual toxicity.
Mammalian Toxicity
Table 10 is an overview of the acute effects
caused by exposure to toxaphene.
General Toxicity. Most acute toxicity
studies of toxaphene in mammals were
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Table 10. Acute effects of toxaphene exposure.
Dose, Type of
Species Route/Duration mg kg-1 day1 effect Effect Reference
Rat Oral/once 90 male Death LD50 (175)
80 female Death LD50
Mouse Oral/once 120 Death LD50 (187)
Guinea pig Oral/once 270 Death LD50 (187)
Cat Oral/once 25-40 Death LD50 (187)
Dog Oral/once 49 Death LD50 (187)
Pheasant Oral/once 40 Death LD50 (188)Quail Oral/once 80-100 Death LD50 (189)
Rainbow trout 10.6 (pg liter1) Death LC50 (190)
Coho salmon 8 (pg literl) Death LC5, (190)
Striped bass 4.4 (pg liter') Death LC50 (191)
Sheepshead minnow 1.1 (pg liter') Death LC50 (191)
Rat Oral/gestation days 6-15, 1 x/day 32 Systemic 50% reduction in body weight (192)
Rat Ad lib/14 days 10 Systemic No body weight gain (NOAEL) (193)
Rat Ad lib/14 days 10 Systemic 20% increase in liver weight (193)
Guinea pig Oral/once 300 Systemic 13% increase in liver weight (194)
Guinea pig Oral/once 300 Pathologic Hypoxic and anoxic changes and (194)
disfigurement of myelin in brain
Guinea pig Oral/60 days 2-6 Pathologic Vacuolization in cells of collecting system and (194)
glomerulus, degeneration of corticol tubular cells
Mice Oral/14 days 50 Pathologic Dilatation of hepatic ER (195)
conducted between 1950 and 1980. As
reviewed by Saleh (1), the acute LD50 of
toxaphene to laboratory mammals ranged
from 5 to 1075 mg kg-', depending on the
species studied and the route of exposure. In
addition, female rats appeared to be some-
what more sensitive to toxaphene exposure
than male rats. Among the most prominent
symptoms observed in laboratory animals
acutely intoxicated by toxaphene are gener-
alized epilepticlike convulsions starting with
excessive saliva production followed by
vomiting and muscle spasms. In time, the
frequency of convulsions increased. Finally,
animals became exhausted and died from
respiratory failure (173). Pathologic changes
upon toxaphene exposure may include
degeneration of the brain, spinal cord, and
pulmonary edema (1).
Combination Toxicity. Because
toxaphene was widely used as a pesticide,
in addition to other pesticides, the toxicity
of toxaphene alone as well as in combi-
nation with other widely used pesticides
was evaluated in ICR mice after 14 days of
oral administration or 90 days in drinking
water (195,196). Overall, decreases in
body weight as well as increases in liver to
body weight ratios were observed in mice
exposed to toxaphene and toxaphene-con-
taining mixtures. Visually, no pathologic
changes were observed in tissues from
treated animals. However, proliferation
along with dilatation and fragmentation of
the endoplasmatic reticulum and scattering
of ribosomes in the liver were pronounced.
Cotreatment of mice with toxaphene and
parathion resulted in higher levels of
inhibition of serum cholinesterase (serum
ChE) activity than did treatment of mice
with toxaphene alone for up to 3 days after
initial exposure. In contrast, an increase of
serum ChE activity was observed in mice
cotreated with toxaphene and 2,4-
dichlorophenoxyacetic acid (2,4-D) com-
pared to mice treated with toxaphene alone.
Phenobarbital-induced sleeping time was
reduced in mice exposed to toxaphene and
toxaphene-containing mixtures, whereas no
reduction was observed in mice exposed to
either parathion or 2,4-D This was probably
because exposure to toxaphene-containing
mixtures induces the hepatic mixed-func-
tion oxygenase (MFO) system. It cannot be
determined from these studies whether the
combination of toxicity of toxaphene and
other pesticides is synergistic or antagonistic
in nature or the result of effects manifested
by their components individually.
Neurotoxicity. Neurotoxic effects of
toxaphene exposure such as effects on
behavior and learning have been reported
to occur (1). The mechanisms underlying
neurotoxicity, however, are little under-
stood. In guinea pig, Chandra and
Durairaj (194) observed histological
changes in the guinea pig brain, e.g.,
hypoxic (disorganization) and anoxic
(enlargement) changes in the neurones,
upon exposure to toxaphene. Depletion of
cytoplasmic organelles in the oligodendritic
cells of the cerebrum was observed in
guinea pigs exposed to 2 mg kg-1 toxa-
phene, whereas disfigurement of myelin in
the brain occurred when they were exposed
to the high 5 mg kg-' day-' dose. In a sub-
sequent study, Chandra and Durairaj
(197) investigated the impact of acute
and subacute toxicity of toxaphene on the
lipid profile in brain, liver, and kidney of
guinea pig. An increase in neutral lipids
and cholesterol and a reduction of phos-
pholipids was observed in the brain. The
individual phosphoglycerides phos-
phatidylinositol, sphingomyelin, and
phosphatidic acid increased in both the
acute and subacutely intoxicated guinea
pig brain. On the basis of their studies,
Chandra and Durairaj (197) postulated
that the observed effects of toxaphene on
lipid contents in brain, liver, and kidney
led to membrane damage. In addition,
alterations in phospholipids and cholestrol
content were thought to be an adaptive
mechanism to cope with the stress due to
toxaphene intoxication. Furthermore, they
argued that the increase of sphingomyelin
in the brain might be related to neurotoxic
symptoms, as an increase in sphingo-
myelin inhibits the permeability of the
membrane to small molecules and ions.
Chandra and Durairaj (184) also
observed reduced ATPase and acetyl-
cholinesterase (AChE) activities in the
brain on acute and subacute exposure of
guinea pigs to similar concentrations of
toxaphene. Addressing the mode of action
of the neurotoxic effects of toxaphene,
Chandra and Durairaj discussed that inhi-
bition of AChE can result in neural and
neuromuscular disorders. In addition,
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respiratory failure, which leads to hypoxic
and anoxic changes, would eventually
result in decreased phosphorylation and
ATP production, as evidenced by inhibi-
tion of ATPases. Toxaphene in vitro
inhibits brain and kidney ATPases in
mammals, as well as in fish, and insects
(1). In contrast to the observed effects on
brain AChE activity in the guinea pig, lit-
tle effects on brain ChE activity were
observed in mice treated with toxaphene
and toxaphene-containing mixtures (195).
The exposure of mice to toxaphene or a
toxaphene-containing mixture did not
result in pathologic changes in brain and
liver at the light microscopic level. Table
11 gives an overview of neurologic, repro-
ductive, and endocrine effects caused by
exposure to toxaphene.
Nephrotoxicity. The effects of
toxaphene exposure on the kidney of
mammals were observed in a number of
studies. In the 1992 study by Chandra and
Durairaj (194), a single administration of
300 mg toxaphene kg` bw to guinea pigs
resulted in no observable changes in the
ultrastructure of the kidney 72 hr after
exposure. In a subacute exposure study, 2
or 6 mg toxaphene kg-l day-l administered
for 60 days led to vacuolization in cells of
the collecting system and glomerulus,
degeneration of corticol tubular cells, vac-
uolization, and an increase in the number
of mitochondria of tubular epithelial.
From this study, the authors evaluated the
toxaphene-induced nephrotic changes as an
adaptive mechanism in the guinea pig to
cope with a disturbance in membrane-asso-
ciated glycoproteins and glycolipid metab-
olism in liver and kidney. In a study on the
impact of acute and subacute effects of
toxaphene on the lipid profile in kidney,
Chandra and Durairaj (197) observed an
increase in phosphatidylcholine, phos-
phatidylinositol, and phosphatidic acid
levels accompanied by a decrease in cardi-
olipin and sphingomyelin contents.
However, no alterations in other phospho-
glyceride contents were found. Both acute
and subacute exposure of the guinea pig to
toxaphene resulted in reduced ATPase and
AChE activities in the kidney (184). This
study also indicated that toxaphene may be
metabolized in the kidney in addition to
the liver, as an enhanced cytochrome P450
content and induced aniline hydroxylase
activity were found in the kidney when
exposed to toxaphene.
Hepatotoxicity. Several studies have
shown that toxaphene or toxaphene-
containing mixtures induce a number of
hepatic biotransformation enzymes.
Toxaphene and combinations of toxaphene
with parathion (5 mg kg-') and/or 2,4-D
(50 mg kg-l) induced hepatic enzymes
such as cytochrome P450, benzo[a]pyrene
hydroxylase, and aliesterase in mice after 7
days of oral exposure. Furthermore, the
in vitro biotransformation of parathion and
paraoxon was effectively enhanced using
hepatic 9000 g supernatant from mice
exposed to toxaphene (202). Toxaphene
and toxaphene-containing mixtures also
decrease the phenobarbital-induced sleep-
ing time in mice, suggesting an effect of
toxaphene on CYP2B-type metabolizing
enzymes (195). These studies show that the
toxaphene-induced increase of appropriate
biotransformation enzymes, including
cytochrome P450, potentially stimulates
the metabolism of a number of other xeno-
biotics and consequently may even reduce
their toxicity.
A single dose of 300 mg toxaphene
kg-' bw in guinea pig did not result in
histopathologic or ultrastructural changes of
the liver, whereas administration of 2 or 5
mg kg-l day-l for 60 days led to a relative
increase in liver weight, chronic venous con-
gestion, mononuclear infiltration, and fatty
changes in hepatocytes (194). The effect of
subacute toxicity of 2 and 5 mg toxaphene
kg` day-l on the hepatic lipid profile was a
decrease of phospholipids without signifi-
cant alterations in glycolipid, neutral lipids,
and cholestrol levels (197). Notably, in this
study the acute dose of 300 mg kg` bw
resulted in piloerection, sedation, crouching,
clonic-tonic convulsions, and death within
72 hr. The changes observed in the lipid
profile were thought to be an adaptive
mechanism to cope with stress associated
with toxaphene intoxication. In a similar
experiment, toxaphene also reduced
hepatic ATPase and AChE activities and
interfered with collagen and calcium
metabolism (184).
Reproductive Effects. Few data are
available on the effects of toxaphene on
reproduction in mammals and fish. Few or
no effects were found in mammals to indi-
cate interference of toxaphene with repro-
duction (203-205). Recently, the effects of
toxaphene on reproduction were studied in
sexually mature female zebrafish after being
fed toxaphene-contaminated food (0.02,
0.23, and 2.2 pg g-l fish day-l) for 2 weeks
(206). In the highest dose group, all fish
died within 24 hr; 9 of 14 fish died in the
group exposed to 0.23 pg g-' fish day'
between days 8 and 12. Other toxic effects
observed in the parent fish were skin discol-
oration, subcutaneous hemorrhages, and
curved backbones in the vertical plane.
With regard to reproductive success, a non-
significant decrease in mean total number of
eggs spawned was observed. No differences
in reproductive success were observed, as
assessed by percentage of viable eggs 24 hr
after fertilization, percentage of embryo
mortality, and percentage of eggs hatching
72 hr after fertilization. In contrast,
toxaphene produced a dose-related decrease
in the percentage of oviposition for female
zebrafish. Hence, it was concluded that
dietary exposure of zebrafish to toxaphene
affects their reproductive process.
Endocrine Toxicity. A recent concern
about many environmental pollutants is
that they might have endocrinelike proper-
ties. Environmental xenobiotics that
mimic steroidal hormones have been impli-
cated in the increasingly high incidence of
breast cancer and other gender-specific dis-
orders (207-209). To determine whether
environmental chemicals act as exogenous
hormones in the American alligator,
Table 11. Neurologic and developmental effects of toxaphene exposure.
In vivo
species Route/Duration Dose, mg kg` day-' Type of effect Effect Reference
Rat Oral/3 days, Ix/day 25 Neurologic Tremors, nervousness (198)
Guinea pig Oral/once 300 Neurologic 10% decreased brain weight (194)
Dog Oral/2 days 10 Neurologic Convulsions, salivation, vomiting (199)
5 Neurologic NOAEL
Rat Ad lib/14 days 10 Developmental NOAEL (193)
Rat Oral/gestation day 7-16, 1 x/day 12.5 Developmental Decreased fetal renal protein (200)
Mouse Oral/gestation day 7-16, lx/day 35 Developmental NOAEL (201)
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Vonier et al. (210) examined the ability of
chemicals to bind to the estrogen receptor
and progesterone receptor in a protein
extract prepared from the oviduct of the
alligator. Unlike some DDT metabolites,
toxaphene did not interact with the estro-
gen receptor. Interestingly, toxaphene
combined with other chemicals decreased
[3H] 17p-estradiol binding in a greater than
additive way.
Possible estrogenic or antiestrogenic
potencies of toxaphene either alone or in
combination with other pesticides were
studied in a number of in vitro systems by
other authors. The effect of toxaphene on
the aromatase enzyme complex, which con-
verts androgenic to estrogenic enzymes, was
studied by Drenth et al. (211) in the human
choriocarcinoma cell line JEG-3. Aromatase
activity did not decrease as a result of
toxaphene exposure. The expression of
estrogen-regulated mRNA-stabilizing fac-
tor (E-RmRNASF) in toxaphene-treated
leghorn rooster liver was studied by deter-
mining the stability of apolipoprotein II
(apoIl) mRNA in vitro. It was shown that
toxaphene prevented estrogen stimulation
of E-RmRNASF expression, acting as an
antiestrogen (212). Toxaphene also
inhibits the binding of progesterone, dex-
amethasone, and testosterone to their
respective receptors (IC20 values of 68.4,
4.2, and 3.5 pM, respectively) isolated
from eggshell gland mucosa of the domestic
owl (213).
In contrast to the antiestrogenic poten-
cies, weakly estrogenic potencies of
toxaphene were observed in a number of
other in vitro test systems. In the human
E-screen test, 10 pm of toxaphene was
shown to be weakly estrogenic (0.0001, as
potent as estradiol). Interestingly, a more-
than-additive estrogenic response was
observed in the human E-screen test after
administration of a mixture of 10 estro-
genic chemicals including toxaphene
(214,215). Bonefeld-J0rgenson et al. (216)
conducted transient gene expression studies
using a chimeric reporter construct con-
taining one estrogen-responsive element
(ERE) to expression of the chlorampheni-
col acetyltransferase (CAT) gene in human
breast cancer cells. They found that techni-
cal toxaphene (10 pM), as well as the
toxaphene congener B[12012]-(212) (10
pM), acted as an antiestrogen that blocked
the action of estrogens by inhibiting the
ER:ERE-activated gene transcription.
In a study by Ramamoorthy et al.
(217), minimal estrogenic potencies of
toxaphene and no synergistic effects of
combinations of toxaphene and other
pesticides were observed. Induction of
CAT activity was not observed in MCF-7
human breast cancer cells transiently
transfected with plasmids containing
estrogen-responsive 5'-promotor regions
from either rat creatine kinase B or
human cathepsin D genes after treatment
with a combination of toxaphene
(1 0-8 _ 10-5 M) or cotreated with toxa-
phene and dieldrin (equimolar concen-
trations, 10-5 M). Furthermore, no
estrogenic response was found in the
uterus of a 21-day-old female B6C3F,
mouse after oral exposure to toxaphene
(2.5-275 ,mole kg-' bw) or to toxaphene
in combination with equimolar concen-
trations of dieldrin. In contrast to the
results obtained with the systems previ-
ously mentioned, Ramamoorthy et al.
(217) observed a slight estrogenic effect in
an estrogen-responsive reporter system in
yeast-expressing mouse estrogen receptor
2.5 hr after treatment with toxaphene
(2.5 10-5 M) or mixtures of toxaphene with
endosulfan, dieldrin, or chlordane. The
latter treatments were not synergistic. In
contrast, no estrogenic effect was observed
in yeast-expressing human estrogen
receptor treated with toxaphene alone or in
combination with other pesticides.
CarcinogeWncty
In the past, much effort has been expended
on studying the carcinogenic properties of
toxaphene. Table 12 gives an overview of
carcinogenic and mutagenic data of
toxaphene presented in the literature.
Toxaphene was found to be highly carcino-
genic in rat and mice and induced malig-
nant liver tumors, reticulum cell sarcomas,
sarcomas in the uterus, neoplasms in the
reproductive system and/or mammary
gland, and neoplasms in the pituitary,
adrenal, and thyroid glands (1,177). The
National Cancer Institute conducted a
study in which neoplasms were found in
the thyroid gland of the rat (218). To
investigate whether the increased incidence
of thyroid tumors observed in the rat in the
National Cancer Institute bioassay of
toxaphene had a nongenotoxic etiology,
Waritz et al. (219) studied the thyroid
function and thyroid tumors in male
Crl:Cd BR (Sprague-Dawley-derived) rats
orally exposed to 75 mg toxaphene
kg-1 day-1 for 28 days (100 mg toxaphene
kg-' day-' was administered for the first
Table 12. Carcinogenicity and mutagenicity data of toxaphene.
In vivo
species Route/Duration Dose, mg kg-1 day-1 Effect Reference
Rat Ad lib/80 weeks 55.6 (males) Follicular-cell carcinomas, (218)
54 (females) thyroid adenomas
Mouse Ad lib/80 weeks 12.9 males Hepatocellular carcinoma (218)
25.7 females Hepatocellular carcinoma
Rat Oral/29 days maximum 100 for 3 days, Thyroid follicularepithelial (219)
75 remaining days hyperplasia, hypertrophy
In vitro
test system Dose Response Reference
Ames test 0-3000 pg/plate Toxaphene mixture mutagenic TA98 (25)
Salmonella strains TA1535, in Salmonella strains and TA100
TA1537, TA1538, TA98, in presence or absence of liver S9.
and TA100 Heptachlorobornane-l not mutagenic in
Salmonella strains TA1535, TA1537,
TA1 538, TA98, and TA100, either with
or without liver S9.
Ames test 0-10,000 pg/mI Toxaphene mutagenic in Salmonella strain (219)
Microsuspension procedure TA100 (2500, 5000, and 10000 pg/mI).
Salmonella strain TA98 and Parlar 26, 50, 62, and 32 not mutagenic in
TA100) Salmonella strain TA100 (strain TA98
not tested).
SCE induction 0-20 pg/mI; Dose- and time-dependent induction of SCEs. (220)
Chinese hamster lung (Don) incubation time Dose-dependent induction of cell-cycle delay.
cells up to 28.5 hr
GJIC 0-10 pg/mI; Dose- and time-dependent inhibition of GJIC. (221)
Normal human breast epithelial incubation time Reduction of phosporylated Cx43 levels.
cells (HBEC) up to 24 hr
Brain PKC activity (mouse) 200 pM Induction of mouse brain PKC activity. (222)
Abbreviations: GJIC, gap junctional intercellular communication; HBEC, human breast epithelial cells.
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4 days). Rats were sacrificed at days 0, 7,
14, and 28 of exposure. A significant time-
dependent increase in serum thyroid-stim-
ulating hormone levels was found, whereas
there were no changes in serum levels of
T3, T4, rT3, and corrected rT3. They
observed a time-dependent increase in thy-
roid follicular cell hypertrophy and
intrafollicular hyperplasia and a decrease
in thyroid follicular cell colloid stores,
both characteristic of a hyperactive thy-
roid. Considering that toxaphene has the
characteristics of a phenobarbital-type
inducer of the cytochrome P450 enzyme
system, the authors concluded that the
increase in thyroid follicular neoplasia in
toxaphene-treated rats probably was caused
by a nongenotoxic mechanism such as that
believed to be responsible for thyroid
tumor increases in rats chronically treated
with phenobarbital. Because this type of
mechanism for thyroid neoplasia is not
known to occur in humans, the authors
also conclude that it becomes increasingly
unlikely that toxaphene presents a hazard
as a thyroid carcinogen for humans.
In an attempt to further elucidate the
mechanism of toxaphene-induced hepato-
carcinogenicity, Hedli et al. (223) inve-
stigated two potential mechanisms:
peroxisomal proliferation, which has been
invoked as a nongenotoxic mechanism of
hepatocarcinogenicity, and DNA adduct
formation. After oral treatment of CD/1
mice for 7 days with toxaphene (0-100 mg
kg-1 day-1), no increases in immuno-
detectable levels of CYP4A1 were detected,
suggesting that peroxisomal proliferation is
not involved in the toxicity of toxaphene.
Furthermore, no evidence was found for
DNA adduct formation in the liver of
toxaphene-treated mice. On the basis of this
study, the authors suggest that the hepato-
carcinogenic properties of toxaphene may be
exerted through a nongenotoxic or promo-
tional mechanism rather than through a
genetic mechanism.
Although in vivo no evidence for a
genetic mechanism for toxaphene-induced
tumor formation was found, in vitro
studies showed that toxaphene is genotoxic
in mammalian cell systems and mutagenic
in the Ames Salmonella test without requir-
ing metabolic activation by liver homo-
genates (1). More recently, Steinberg et al.
(224) tested toxaphene and four toxa-
phene congeners, B[12012]-(202),
B[12012]-(212), B[30030]-(122), and
B[30012]-(1 1 1), for mutagenic activity in
Salmonella typhimurium strains TA98 and
TA100 using a validated microsuspension
procedure instead of the usual plate-
incorporated procedure. Toxaphene was
mutagenic only in the TA100 strain at con-
centrations of 2,500, 5,000, and 10,000 pg
m1-1. In contrast, toxaphene was also muta-
genic to strain TA98 at a concentration of
10,000 pg plate-1 when using the plate-
incorporated assay. Using the microsuspen-
sion method, none of the four tested
toxaphene congeners showed mutagenic
activity in strain TA100 at any of the con-
centrations tested (maximum concentra-
tion: 10,000 pg ml-1). A dose-dependent
(10-10,000 kg plate-') increase in His
revertants was also observed in strains
TA97, TA98, TA100, TA102, and TA104
by Schrader et al. (225) in the absence
of S9 metabolic activation. Genotoxicity
of the technical toxaphene, as well as
B[30012]-(111), but not B[12012]-(202),
B[12012]-(212), and B[30030]-(122), was
also demonstrated by Boon et al. (128)
using the Mutatox assay. Addition of rat
S9 fraction or microsomes of harbor seal
and albatross decreased the genotoxic
potential of the tested congeners and
toxaphene. More in vitro evidence for
genotoxicity was found by Sobti et al.
(226) showing toxaphene-induced sister-
chromatid exchange (SCE) in cultured
lymphoblasts. In contrast, Schrader et al.
(225) could not demonstrate convincing
evidence of a toxaphene-induced (1-10 pg
ml-l) dose-dependent SCE induction at
the HGPRT gene locus in V79 cells.
Knowing that cell-cycle delay may
interfere with the expression of genotoxic-
ity, Steinel et al. (220) studied the effect of
cell-cycle delay on the induction of SCE by
toxaphene in Chinese hamster lung (Don)
cells. They found that toxaphene exhibited
a dose- and time-dependent decrease in
cell-cycle progression. At similar concentra-
tions of toxaphene, higher numbers of
SCEs were observed and dose and treat-
ment time relationships were demonstrated.
Hence, SCE induced by toxaphene was not
masked by mitotic delay and longer
toxaphene treatment times were not neces-
sary in Don Chinese hamster cells.
Nevertheless, the authors support recom-
mendations for prolonged incubation times
in SCE assays affected by mitotic delay.
To study a promotional mechanism
rather than a genetic mechanism for
toxaphene-induced tumor formation, Kang
et al. (221) studied the inhibition of gap
junctional intercellular communication
(GJIC) by toxaphene. Noncytotoxic concen-
trations of toxaphene (0-10 pg ml-1) inhib-
ited GJIC in normal human breast epithelial
cells reversibly in a dose-dependent manner
after 90 min of exposure. In an attempt to
determine how toxaphene inhibited
GJIC, Kang and co-workers (221) exam-
ined Cx43 protein in cells treated with
toxaphene. A reduction in the number of
gap junctional plaques and induction of
hypophosphorylation of Cx43 in normal
human breast epithelial cells were obser-
ved at toxaphene concentrations that
affected GJIC. In addition, these studies
also showed that toxaphene inhibits GJIC
through a nonestrogen receptor mecha-
nism, as the cells used in these studies do
not express the estrogen receptor. An
alternative working hypothesis suggesting
a central role for protein kinase C (PKC)
has been proposed for skin tumor pro-
motion (227). Moser and Smart (222)
examined the potency of some hepatocar-
cinogenic organochlorine pesticides to
stimulate PKC in vitro in mouse brain,
hepatic, and epidermal homogenates.
Two hundred pM toxaphene increased
brain PKC 469-fold. The induction was
phospholipid and calcium dependent. It is
premature to conclude from this result,
however, that stimulation of PKC activity
is involved in toxaphene-induced hepatic
tumor promotion.
Toxaphene, a Human Risk Factor
As mentioned previously, toxaphene is
carcinogenic in rats and mice and also has
been proven to be mutagenic (1,178). Such
findings have led to the assumption that
toxaphene poses a risk as a human carcino-
gen. Human exposure to toxaphene occurs
mainly through the consumption of conta-
minated fish or by occupational exposure.
Data are scarce on the risk to humans from
toxaphene exposure (1). Brown et al. (228)
and Cantor et al. (229) evaluated the asso-
ciation between elevated risk of leukemia
and non-Hodgkin's lymphoma (NHL)
among farmers and exposure to pesticides
and other agricultural chemicals and con-
cluded that there is an elevated risk ofNHL
among farmers. Risk increased in cases in
which farmers personally handled, mixed,
or applied pesticides, did not use protective
clothing, and when more specific active
mixures of pesticide exposure were used.
Chemicals most strongly associated with
risk of NHL were carbaryl, chlordane,
DDT, diazinon, dichlorvos, lindane,
malathion, nicotine, and toxaphene.
Although studies like these contribute
to our knowledge about the toxicity of
toxaphene for humans, difficulties arise in
the interpretation of human risk. In an
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International Agency for Research on
Cancer evaluation of the carcinogenic risk
of toxaphene to humans, toxaphene was
regarded a carcinogenic risk to humans on
the basis of evidence that toxaphene is car-
cinogenic in rats and mice and, despite the
lack of adequate data, humans (230). To
date most studies on carcinogenicity of
toxaphene have been conducted using
technical toxaphene mixtures. Human
exposure, however, is mainly through con-
sumption of toxaphene-contaminated fish.
Composition of toxaphene mixtures is
changed from original technical mixtures
through weathering conditions and internal
metabolism. Human exposure, therefore, is
to a mixture other than technical toxa-
phene. The toxic and carcinogenic proper-
ties of fishborne residues of toxaphene are
unknown. Under the auspices of the
European Union (EU)-funded project
MATT, our laboratories are involved in a
semichronic exposure study in a joint effort
to produce and isolate fish (cod)-based
toxaphene residues that are chemically char-
acterized and toxicologically evaluated, par-
ticularly for genotoxicity (in vitro) and
tumor promotion capacity.
Legislation of Toxaphene
in Food
In 1976 a European directive regulating
residues of toxaphene in fruits and vegeta-
bles (0.4 mg kg-') was issued (231) that
was integrated into the national food laws
of all member states in the EU. At that
time toxaphene was still used as a pesticide.
In 1982 the European maximum residue
limit (MRL) for fruits and vegetables was
extended to some food of animal origin
such as meat and meat products, milk and
milk products, and animal edible fat in the
German MRL ordinance (232). During
that period no reports or data about toxa-
phene residues were published. On the
basis of growing toxicologic concerns
when toxaphene was internationally classi-
fied as a compound possibly carcinogenic
to humans (1), the European MRL for
fruits and vegetables was further reduced
in 1993 to 0.1 mg kg-1 ww (233), equal
to the limit of determination of common
residue analysis methods. Thus, residues of
toxaphene should not be found in these
foods. In 1994 during implementation of
this regulation into the German MRL
Ordinance, this strict MRL was extended
to all food of animal origin (234) includ-
ing fish and fish products. For fatty fish
(lipid content > 10%) the MRL was set at
0.1 mg kg-1 lipid weight, for lean fish
with a lipid content > 10%, the MRL was
set as at 0.01 mg kg-' ww. In general the
previously mentioned regulations were
based on total toxaphene levels. At the
beginning of the 1990s a sensitive residue
analysis method by GC-ECD and
GC-NCI/MS using three individual chlo-
rinated bornane congeners, B[12012]-
(202), B[12012]-(212), and B[30030]-
(122), was developed in Germany (11,92).
The method was applied in routine analyses
of many German laboratories and vali-
dated by an interlaboratory exercise
(99,235). First reports indicated that rela-
tively high concentrations of these
toxaphene congeners were in some fish
from the North Atlantic, an area from
which much of Germany's fish stock is
derived (100). It was obvious that some
edible fish would exceed this low MRL.
Therefore, the new regulation for fish, fish
products, and mussels was suspended until
the end of 1996 (234,236) to give legisla-
tors time to determine the level at which
the MRL should be established to take
into account the questions of, on the one
hand, an acceptable level of consumer pro-
tection and, on the other hand, the neces-
sary supply of fish and fish products. In
the interim, data about the contamination
of all edible fish by the three indicator
congeners were collected and evaluated in
order to calculate the average toxaphene
intake through consumption of fish (0.22
jg person-1 day'1) (237). At present there
is no acceptable daily intake (ADI) value
for toxaphene for use in conducting a risk
assessment study. Therefore, the average
toxaphene intake was compared with the
lowest no-observed adverse effect level
(NOAEL) considering a sufficient high
safety factor (-25,000-50,000). In 1997 a
new concept was incorporated into the
German MRL for toxaphene in food of
animal origin. The MRL for fish and fish
products was set at 0.1 mg kg4l ww on the
basis of the sum of the three indicator con-
geners (238); the MRL for all other food
of animal origin was set at 0.1 mg kg-l on
the basis of total toxaphene. The German
government plans to adjust the MRL in
the future on the basis of the toxaphene
indicator congener concept. The German
ordinance is the first national MRL for fish
on the basis of toxaphene congeners.
The United States and Canada are the
only countries to have established toler-
ance levels for toxaphene in food con-
sumed by humans. The U.S. tolerance
level was set at 5 mg kg-1 ww; however,
this was withdrawn in the early 1990s.
Instead of using a tolerance level, Canada
uses an ADI value of 0.2 pg kg-1 bw. The
calculated daily intake values from the
results of Alder et al. (100) stay below this
Canadian acceptable daily intake.
ACKNOWLEDGMENT: The preparation of this
review was made possible by grant no. FAIR
PL.96.3131 of the European Commission, DG
XIV, FAIR Programme.
REFERENCES AND NOTES
1. Saleh MA. Toxaphene: chemistry, biochemistry,
toxicity, and environmental fate. Rev Environ
Contam Toxicol 118:1-85 (1991).
2. Bidleman TF, Patton GW, Walla MD, Hargrave
BT, Vass WP, Erickson P, Fowler B, Scott V,
Gregor DJ. Toxaphene and other organochlo-
rines in arctic ocean fauna: evidence for
atmospheric delivery. Arctic 42:307-313
(1989).
3. Terriere LC, Kiigemagi U, Gerlach AR, Borovicka
RL. The persistence of toxaphene in lake water
and its uptake by aquatic plants and animals.
J Agric Food Chem 14:66-69 (1966).
4. Zell M, Ballschmitter K. Baseline studies of
global pollution. Il: Global occurrence of hexa-
chlorobenzene (HCB) and polychlorocamphenes
(PCC) in biological samples. Fresenius Z Anal
Chem 300:387-402 (1980).
5. Niethammer KR, Baskett TS, White DW.
Organochlorine residues in three heron species
as related to diet and age. Bull Environ Contam
Toxicol 33:491-498 (1984).
6. Skaare JU, Tuveng JM, Sande HA. Organo-
chlorine pesticides and polychlorinated
biphenyls in maternal adipose tissue, blood,
milk, and cord blood from mothers and their
infants living in Norway. Arch Environ Toxicol
17:55-63(1988).
7. de Boer J, Wester PG. Determination of
toxaphene in human milk from Nicaragua and
in fish and marine mammals from the north-
eastern Atlantic and the North Sea.
Chemosphere 27:1879-1890 (1993).
8. Norstrom RJ, Muir DCG. Chlorinated-hydrocar-
bon contaminants in Arctic marine animals. Sci
Total Environ 151:107-128 (1994).
9. Kidd KA, Schindler DW, Muir DCG, Lockhart
WL, Hesslein RH. High concentration of
toxaphene in fishes from a subarctic lake.
Science 269:240-242 (1995).
10. Oehme M, Schlabach M, Kallenborn R, Haugen
JE. Sources and pathways of persistent poly-
chlorinated pollutants to remote areas of the
north Atlantic and levels in the marine food
chain: a research update. Sci Total Environ
186:13-24 (1996).
11. Burhenne J, Hainzl D, Xu L, Vieth B, Alder L,
Parlar H. Preparation and structure of high-chlo-
rinated bornane derivates for the quantification
of toxaphene residues in environmental sam-
ples. Fresenius J Anal Chem 346:779-785
(1993).
12. Parlar H, Angerhofer D, Coelhan M, Kimmel L.
HRGC and HRGC-ECNI determination of
toxaphene residues in fish with a new 22
Environmental Health Perspectives * Vol 107, Supplement 1 * February 1999 139
de GEUS ET AL.
components standard. Organohalogen
Compounds 26:357-362 (1995).
13. Pollock GA, Kilgore WW. Toxaphene. In:
Residue Reviews. Vol 69 (Gunther FA, Gunther
JD, eds). New York/Berlin/Heidelberg:Springer-
Verlag, 1978;87-140.
14. Fingerling GM, Coelhan M, Angerhofer D,
Parlar H. Structure-stability relationship of chlo-
rinated bornanes in the environment. Organo-
halogen Compounds 33:17-22 (1997).
15. Buser HR, Muller MD. Isomer- and enantiomer-
selective analyses of toxaphene components
using chiral high-resolution gas chromatogra-
phy and detection by mass spectrometry/mass
spectrometry. Environ Sci Technol 28:119-128
(1994).
16. Nordic Council of Ministers. Nordic risk assess-
ment of toxaphene exposure. TemaNord 540
(1997).
17. Saleh MA, Casida JE. Reductive dechlorination
of the toxaphene component 2,2,5-endo,6-
exo,8,9,10-heptachlorobornane in various
chemical, photochemical and metabolic sys-
tems. J Agric Food Chem 26:583-590 (1978).
18. Parlar H, Grab S, Nitz S, Korte F. Contribution to
ecological chemistry. CXXVII: Photochemistry of
toxaphene: reaction of chlorinated bornane
derivatives in solution and adsorbed on silica
gel. Chemosphere 5:333-338 (1976).
19. Korte FL, Schoenert I, Parlar H. Camphechlor, a
special report. Int Union Pure AppI Chem
51:1561 (1979).
20. Anonymous. Toxaphene: Report of the Scientific
Committee for Pesticides 18/12/80, 1980.
21. Wania F, Shui WY, Mackay D. Measure of the
vapour pressure of several low volatility
organochlorine chemicals at low temperatures
with a gas saturation method. J Chem Eng Data
39:572-577 (1994).
22. Mackay D. Multimedia Environmental Models,
The Fugacity Approach. Chelsea, MI:Lewis
Publishers, 1991.
23. Howard PH, ed. Handbook of Environmental
Fate and Exposure Data. Chelsea, MI:Lewis
Publishers, 1991.
24. Sullivan JR, Armstrong DE. Toxaphene Status
in the Great lakes, Priority Pollutants Status.
Rpt no 2. WIS-SG-85-241. Madison Wl:
University of Wisconsin, 1985;39.
25. Hooper NK, Ames BN, Saleh MA, Casida JE.
Toxaphene, a complex mixture of polychloroter-
penes and a major insecticide, is mutagenic.
Science 205:591-593 (1979).
26. Kucklick JR, Bidleman TF, McConnel LL, Walla
MD, lvanov GP. Organochlorines in the water
and biota of lake Baikal, Siberia. Environ Sci
Technol 28:31-37 (1994).
27. Wania F, Mackay D. Modelling the global dis-
tribution of toxaphene: a discussion of feasabil-
ity and desirability. Chemosphere 27:2079-
2094 (1993).
28. El-Sebae AH, Abou Zeid MA, Saleh MA. Status
and environmental impact of toxaphene in the
Third World-a case study of African agricul-
ture. Chemosphere 27:2063-2072 (1993).
29. Murphy TJ, Mullin MD, Meyer JA. Equila-
bration of polychlorinated biphenyls and
toxaphene with air and water. Environ Sci
Technol 21 :155-162 (1997).
30. McConnel LL, Cotham WE, Bidiman TF. Gas
exchange of hexachlorocyclohexane in the
Great Lakes. Environ Sci Technol 27:1304-1311
(1993).
31. McConnell LL, Kucklick JR, Bidleman TF, Walla
MD. Long-range atmospheric transport of
toxaphene to Lake Baikal. Chemosphere 27:
2027-2036 (1993).
32. Tateya S, Tanabe S, Tatsukawa R. PCB's on the
globe: possible trend of future levels in the
open-ocean environment. In: Toxic Contami-
nation in Large Lakes, Vol IlIl (Schidtke NW, ed).
Chelsea, Mi:Lewis Publishers, 1988;237-281.
33. Bidleman TF, Falconer RL, Walla MD. Toxa-
phene and other organochlorine compounds in
air and water at Resolute Bay, N.W.T., Canada.
Sci Total Environ 160/161:55-63 (1995).
34. Hoff RM, Bidleman TF, Eisenreich SJ.
Estimation of PCC loadings from the atmos-
phere to the Great Lakes. Chemosphere
27:2047-2055 (1993).
35. Muir DCG, Boer J de. Recent developments in
the analysis and environmental chemistry of
toxaphene with emphasis on the marine envi-
ronment. Trends Anal Chem 14:56-66 (1995).
36. Fingerling GM, Hertkorn N, Parlar H. Formation
and spectroscopic investigation of two hexa-
chlorobornanes from six environmentally rele-
vant toxaphene components by reductive
dechlorination in soil under anaerobic condi-
tions. Environ Sci Technol 30:2984-2992
(1996).
37. Wester PG, Geus H-J de, Boer J de, Brinkman
UATh. Simple nomenclature for chlorinated bor-
nanes, bornenes and bornadienes from which
structural information can be directly deduced.
Chemosphere 35:1187-1194 (1997).
38. Voldner EC, Smith L. Production, usage and
atmospheric emissions of 14 priority toxic
chemicals, Appendix II. In: The Workshop on
the Estimation of Atmospheric Loadings of
Toxic Chemicals to the Great Lakes, Oct 1986,
Scarborough, Ontario, Windsor, ONT: Inter-
national Joint Commission, 1990.
39. Rapaport RA, Eisenreich SJ. Atmospheric depo-
sition of toxaphene to eastern North America
derived from peat accumulation. Atmos Environ
12:63-68 (1986).
40. WHO. Camphechlor. Environmental Health
Criteria 45. ISBN 92 44 1541857. Geneva:World
Health Organization, 1984.
41. Voldner EC, Li YF. Global usage of toxaphene.
Chemosphere 27:2073-2078 (1993).
42. Von Rumker R, Lawless A, Meiners A,
Lawrence K, Kelsco G, Haray F. Production,
Distribution, Use and Environmental Potential
of Selected Pesticides. EPA-540/1-74-001. PB
238795. Springfield, VA:National Technical
Information Service, 1974.
43. Bidleman TF, Zaranski M T, Walla MD.
Toxaphene: usage, aerial transport and deposi-
tion. In: Toxic Contamination in Large Lakes.
Vol (Schidtke NW, ed). Chelsea, MI:Lewis
Publishers, 1988;257-284.
44. Voldner EC, Schroeder WH. Modeling of atmos-
pheric transport and deposition of toxaphene
into the Great Lakes ecosystem. Atmos Environ
23:1949-1961 (1989).
45. Swackhamer DL, McConnell LL, Gregor DJ.
Workgroup report on environmental transport
and fate. Chemosphere 27:1835-1840 (1993).
46. Wideqvist UB, Jansson B, Olsson M, Odsjo T,
Reutergardh L, Uvemo U-B. Temporal trends of
PCC in guillemot eggs from the Baltic. Chemo-
sphere 27:1987-2001 (1993).
47. Sukhoruchenko G1, Alexakhina VV, Kamilova
AV, Zverev AA. Changes in an assortment of
chemical means of attack on insects in cotton
fields during 1960-1982. In: Results of the State
Testing of Pesticides in 1961-1981. Leningrad:
Leningrad Publ of All-Union Institute of Plant
Defence, 1983;21-22.
48. Rantio T, Paasivirta J, Lahtipera M. Studies on
toxaphene in the environment. I: Experiences
on analytical behaviour of PCCs. Studies includ-
ing pulp mill wastes. Chemosphere 27:2003-
2010 (1993).
49. Paasivirta J, Rantio T, Koistinen J, Vuorinen PJ.
Studies on toxaphene in the environment - II.
PCCs in Baltic and Arctic Sea and lake fish.
Chemosphere 27:2011-2015 (1993).
50. Lockhart WL, Saleh MA, El Sebae AH,
Doubleday N, Evans M, Jansson B, Jerome V,
Walker JB, Witteman J. Report of working
group on toxicology of chlorinated bornane com-
pounds. Chemosphere 27:1841-1848 (1993).
51. Rappe C, Haglund P, Buser HR, MOller MD.
Enantioselective determination of chiral
chlorobornanes in sediments from the Baltic
Sea. Organohalogen Compounds 31:233-237
(1997).
52. Stern GA, Loewen MW, Miskimmin BM, Muir
DCG, Westmore JB. Characterization of two
major toxaphene components in treated lake
sediment. Environ Sci Technol 30:2251-2258
(1996).
53. Swackhamer DL, Pearson RF, Schottler S.
Biomagnification of toxaphene in the lake
Michigan lower foodweb. Organohalogen
Compounds 33:39-41 (1997).
54. Health Canada. Report on Human Health
Significance of Toxaphene in Lake Superior Fish
Species. Ottawa, ON:Bureau of Chemical
Safety, 1995.
55. Health Canada. Report on Human Health
Significance of Toxaphene in Lake Laberge Fish.
Ottawa, ON:Bureau of Chemical Safety, 1992.
56. Bidleman TF, Walla MD, Muir DCG, Stern GA.
Selective accumulation of polychlorocam-
phenes in aquatic biota from the Canadian arc-
tic. Environ Toxicol Chem 12:701-709 (1993).
57. De Pinto JV, Feist T, Smith D. Analysis of
toxaphene behaviour in Great Lakes.
Organohalogen Compounds 33:280-284 (1997).
58. Swackhamer DL, Pearson RF, Eisenreich SJ,
Long DT. Past and present accumulation of
polychlorinated bornanes in Great Lakes sedi-
ment. Organohalogen Compounds 26:319-322
(1995).
59. Howdeshell MJ, Hites RA. Historical input and
degradation of toxaphene in Lake Ontario sedi-
ment. Environ Sci Technol 30:220-224 (1996).
60. Scheel RH. GC/ECNI-MS/MS for the structural
determination of chlorinated bicyclic monoter-
penes in Michigan Great Lakes sport fish.
Organohalogen Compounds 33:57-62 (1997).
61. Stuthridge TR, Wilkins AL, Langdon AG.
Identificatin of novel chlorinated monoterpenes
formed during kraft pulp bleaching of Pinus
radiata. Environ Sci Technol 24:903-908 (1990).
62. Saleh MA. Capillary gas chromatography-elec-
tron impact and chemical ionization mass spec-
trometry of toxaphene. J Agric Food Chem
31:748-751 (1983).
140 Environmental Health Perspectives * Vol 107. Supplement * February 1999
TOXAPHENE: OCCURRENCE, ANALYSIS, AND TOXICOLOGY
63. Hainzl D. Spectroscopic behavior and X-ray
analysis of the toxaphene component 2,2,3-
exo,8b,8c,9c,10a-heptachlorocamphene. J
Agric Food Chem 43:277-280 (1995).
64. Vetter W. Toxaphene, theoretical aspects of
the distribution of chlorinated bornanes includ-
ing symmetrical aspects. Chemosphere
26:1079-1084 (1993).
65. Coelhan M, Fingerling G, Angerhofer D, Parlar
H. Schwerpunktthema: Toxaphen in der
Umwelt, Teil I: Verhalten und Verbleib des
lnsektizids Toxaphen in der Umwelt. Z
Umweltchem Okotox 10:37-59 (1998).
66. Hainzl D, Burhenne J, Parlar H. Theoretical con-
sideration of the structural variety in the
toxaphene mixture taking into account recent
experimental results. Chemosphere 28:245-252
(1994).
67. Jansson B, Wideqvist U. Analysis of toxaphene
(PCC) and chlordane in biological samples by
NCI mass spectrometry. Intern J Environ Anal
Chem 13:309-321 (1983).
68. Zhu J, Mulvihill MJ, Norstrom RJ. Charac-
terization of technical toxaphene using
combined high-performance liquid chromatog-
raphy-gas chromatography-electron capture
negative ionization mass spectrometry tech-
niques. J Chromatogr A 669:103-117 (1994).
69. de Boer J, de Geus H-J, Brinkman UATh.
Multidimensional gas chromatographic analysis
of toxaphene. Environ Sci Technol 31:873-879
(1997).
70. Sergeant DB, Onusaka Fl. Analysis of
toxaphene in environmental samples. In:
Analysis of Trace Organics in the Aquatic
Environment (Afgan BK, Chau ASY, eds). Boca
Raton, FL:CRC Press, 1989:69-118.
71. Krock B, Vetter W, Luckas B, Scherer G.
Structure elucidation of a main heptachloro
congener of toxaphene in marine organisms
after isolation from melipax. Chemosphere
33:1005-1019 (1996).
72. Andersson 0, Wartanian A. Levels of polychlo-
rinated camphenes (toxaphene), chlordane
compounds and polybrominated diphenyl ethers
in seals from Swedish waters. Ambio
21:550-552 (1992).
73. Muir DCG, de Boer J Toxaphene: analytical
chemistry. Chemosphere 27:1827-1834 (1993).
74. Andrews P, Vetter W. A systematic nomencla-
ture system for toxaphene congeners. Part 1:
Chlorinated bornanes. Chemosphere 31:
3879-3886 (1995).
75. Coelhan M, Parlar H. The nomenclature of chlo-
rinated bornanes and camphenes relevant to
toxaphene. Chemosphere 32:217-228 (1996).
76. Vetter W. Personal communication.
77. Hainzl D, Burhenne J, Barlas H, Parlar H.
Spectroscopic characterization of environmen-
tally relevant C10-chloroterpenes from a photo-
chemically modified toxaphene standard.
Fresenius J Anal Chem 351:271-285 (1995).
78. Nikiforov VA, Tribulovich VG, Karavan VS. On
the nomenclature of toxaphene congeners.
Organohalogen Compounds 26:393-396 (1995).
79. Oehme M, Kallenborn R. A simple code for
polychlorinated compound classes allowing an
unequivocal derivation of the steric structure. I:
Polychlorinated biphenyls and bornanes.
Chemosphere 30:1739-1750 (1995).
80. Wester PG, de Geus H-J, de Boer J, Brinkman
UATh. Simple nomenclature for chlorinated
camphenes and dihydrocamphenes from which
structural information can be directly deduced.
Chemosphere 35:2857-2860 (1997).
81. Lau B, Weber D, Andrews P. GC/MS analysis of
toxaphene: a comparative study of different
mass spectrometric techniques. Chemosphere
32:1021-1 041 (1996).
82. Ballschmiter K, Bacher R, Mennel A, Fischer R,
Riehle U, Swerev M. The determination of chlo-
rinated biphenyls, chlorinated dibenzodioxins,
and chlorinated dibenzofurans by GC-MS. J
High Resolut Chromatogr 15:260-270 (1992).
83. Hainzl D. PhD Thesis. Kassel, Germany:
Universit3t Gh Kassel, 1994.
84. Musial CJ, Uthe JF. Widespread occurrence of
the pesticide toxaphene in Canadian east coast
marine fish. Intern J Environ Anal Chem 14:
117-126(1983).
85. Parlar H. Chlorierte Bornan-Derivate-ein neue
Klasse umweltrelevanter Chemikalien. Nachr
Chem Tech Lab 39:26-37 (1991).
86. Carlin FJ Jr, Hoffman M. The effect on calcu-
lated results of analysis caused by the variabil-
ity among toxaphene reference standards.
Organohalogen Compounds 33:70-75 (1997).
87. Malaiyandi M, Buchanan GW, Nikiforov V,
Williams DT. Large scale isolation and spectro-
scopic characterisation of 2,2,5-endo, 6-exo,
8,9,10-heptachlorobornane from chlorination of
camphene. Chemosphere 27:1849-1856 (1993).
88. Hainzl D, Burhenne J, Parlar H. Isolation and
characterization of environmental relevant sin-
gle toxaphene components. Chemosphere
27:1857-1863 (1993).
89. van der Valk F, Wester PG. Determination of
toxaphene in fish from Northern Europe.
Chemosphere 22:57-6 (1991).
90. Ribick MA, Dubay GR, Petty JD, Stalling DL,
Schmitt CJ. Toxaphene residues in fish: identifi-
cation, quantification, and confirmation at part
per billion levels. Environ Sci Technol 16:
310-318(1982).
91. Brumley WC, Brownrigg CM, Grange AH.
Determination of toxaphene in soil by electron-
capture negative ion mass spectrometry after
fractionation by high-performance gel perme-
ation chromatography. J Chromatogr 633:
177-183 (1993).
92. Alder L, Vieth B. A congener-specific method
for the quantification of camphechlor
(toxaphene) residues in fish and other food-
stuffs. Fresenius J Anal Chem 354:81-92
(1996).
93. Oetjen K, Karl H. Levels of toxaphene indicator
compounds in fish meal, fish oil and fish feed.
Chemosphere 37:1-11 (1998).
94. Muir DCG, Ford CA, Grift NP, Stewart REA,
Bidleman TF. Organochlorine contaminants in
narwhal (Monodon monoceros) from the
Canadian Arctic. Environ Pollut 75:307-316
(1992).
95. Lach G, Parlar H. Comparison of several detec-
tion methods for toxaphene residue analysis.
Toxicol Environ Chem 209:21-32 (1991).
96. Krock B, Vetter W, Luckas B. PCB/toxaphene
group separation on silica prior to congener
specific determination of compounds of techni-
cal toxaphene in fish and other samples by gas
chromatography/electron capture detection.
Chemosphere 35:1519-1530 (1997).
97. Bartha R, Klobes U, Vetter W, Luckas B. Liquid
chromatographic profiles of compounds of tech-
nical toxaphene (CTTs). Organohalogen
Compounds 35:247-250 (1998).
98. Andrews P, Headrick K, Pilon J-C, Lau B, Weber
D. An interlaboratory round robin study on the
analysis of toxaphene in a cod liver oil standard
reference material. Chemosphere 31:4393-
4402 (1995).
99. Alder L, Bache K, Beck H, Parlar H. Collaborative
study on toxaphene indicator compounds
(chlorobornanes) in fish oil. Chemosphere
35:1391-1398 (1997).
100. Alder L, Beck H, Khandker S, Karl H, Lehmann I.
Levels of toxaphene indicator compounds in
fish. Chemosphere 34:1389-1400 (1997).
101. Bartha R, Vetter W, Luckas B. Optimized pres-
sure-pulse splitless injection and electron-cap-
ture, negative ionization detection for the
congener specific determination of compounds
of technical toxaphene. Fresenius J Anal Chem
358:812-817 (1997).
102. Alawi M, Barlas H, Hainzl D, Burhenne J,
Coelhan M, Parlar H. A contribution to the
HRGC-MS and HRGC-ECD response factors of
the environmental relevant toxaphene con-
geners. Fresenius Environ Bull 3:350-357 (1994).
103. Vetter W, Muller U, Krock B, Luckas B. Congener
specific separation of compounds of technical
toxaphene (CCTs) on a non-polar CP-sil 2 phase.
In: Proceedings of the 18th International
Symposium on Cappil Chromatography, 20-24
May 1996, Riva del Garda, Italy. Vol II.
Heidelberg:H0thig, 1996;841-850.
104. Baycan-Keller R, Oehme M. Isomer and enan-
tiomer specific separation of 16 toxaphene con-
geners by HRGC on different stationary phases.
Organohalogen Compounds 33:1-6 (1997).
105. Coelhan M, Fingerling G, Christ G, Parlar H.
Toxaphen in der Umwelt. Teil Il: Analytik von
toxaphenruckstanden. Z Umweltchem Okotox
10:109-122 (1998).
106. Nikiforov VA, Tribulovich VG, Bolshakov S.
Structure-behaviour relationships for toxaphene
congeners. I: Gas chromatography of chlori-
nated bornanes. Organohalogen Compounds
28:355-358 (1996).
107. Karlsson H, Oehme M. Comparison of retention
time overlaps of toxaphene congeners on three
different stationary phases in cod liver sam-
ples and consequences for quantification.
Organohalogen Compounds 28:369-374 (1996).
108. de Geus H-J, de Boer J, Brinkman UATh.
Multidimensionality in gas chromatography.
Trends Anal Chem 15:398-408 (1996).
109. Baycan-Keller R, Oehme M. Thermal decompo-
sition of toxaphene congeners by high resolu-
tion gas chromatographic phases. J High
Resolut Chromatogr 21:298-302 (1998).
110. Bushey MM, Jorgenson JW. Automated instru-
mentation for comprehensive two-dimensional
high-performance liquid chromatography of pro-
teins. Anal Chem 62:161-167 (1990).
111. Phillips JB, Xu J. Comprehensive multi-dimen-
sional gas chromatography. J Chromatogr A
703:327-334 (1995).
112. de Geus H-J, de Boer J, Phillips JB, Ledford EB
Jr, Brinkman UATh. Increased signal amplitude
due to mass conservation in a thermal desorp-
tion modulator. J High Resolut Chromatogr
21:411-413 (1998).
Environmental Health Perspectives * Vol 107, Supplement 1 * February 1999 141
de GEUS ET AL.
113. Andrews P, Newsome WH, Boyle M, Collins P.
High resolution selective ion monitoring GC-MS
determination of toxaphene in Great lakes fish.
Chemosphere 27:1865-1872 (1993).
114. Barrie L, Bidleman T, Dougherty D, Fellin P,
Grift N, Muir D, Rosenberg B, Stern G, Toom D.
Atmospheric toxaphene in the high Arctic.
Chemosphere 27:2037-2046 (1993).
115. Swackhamer DL, Charles MJ, Hites RA.
Quantitation of toxaphene in environmental
samples using negative ion chemical ionization
mass spectrometry. Anal Chem 59:913-917
(1987).
116. Vetter W, Klobes U, Krock B, Luckas B.
Congener-specific separation of compounds of
technical toxaphene on a nonpolar CP-Sil 2
phase. J Microcol Sep 9:29-36 (1997).
117. Chan HM, Zhu J,Yeboah F. Determination of
toxaphene in biological samples using high res-
olution GC coupled with ion trap MS/MS.
Chemosphere 36:2135-2148 (1998).
118. Fowler B, Hoover D, Hamilton MC. The quantifi-
cation of toxaphene in environmental samples.
Chemosphere 27:1891-1905 (1993).
119. Xu L, Hainzl D, Burhenne J, Parlar H. HRGC-
ECD and HRGC-NICI SIM quantification of
toxaphene residues in selected marine organ-
ism by environmentally relevant chlorobor-
nanes as standard. Chemosphere 28:237-243
(1994).
120. Mossner S, Spraker TR, Becker PR, Ballschmiter
K. Ratios of enantiomers of alpha-HCH and
determination of alpha-, beta-, and gamma-
HCH isomers in brain and other tissues of
neonatal northern fur seals (callorhinus ursi-
nus). Chemosphere 24:1171-1180 (1992).
121. Muller MD, Schlabach M, Oehme M. Fast and
precise determination of ax-hexachlorohexane
enantiomers in environmental samples using
chiral high-resolution gas chromatography.
Environ Sci Technol 26:566-569 (1992).
122. Oehme M, Kallenborn R, Wiberg K, Rappe C.
Simultaneous enantioselective separation of
chlordanes, a nonachlor compound, and
o,p'-DDT in environmental samples using tan-
dem capillary columns. J High Resolut
Chromatogr 17:538-588 (1994).
123. Glausch A, Blanch GP, Schurig V. Enantio-
selective analysis of chiral polychlorinated
biphenyls in sediment samples by multidi-
mensional gas chromatography-electron-
capture detection after steam distillation-
solvent extraction and sulfur removal.
J Chromatogr A 723:399-404 (1996).
124. Kallenborn R, Oehme M, Vetter W, Parlar H.
Enantiomer selective separation of toxaphene
congeners isolated from seal blubber and
obtained by synthesis. Chemosphere 28:89-98(1994).
125. de Geus H-J, Baycan-Keller R, Oehme M, de
Boer J, Brinkman UATh. Enantiomer ratios of
bornane congeners in biological samples using
heart-cut gas chromatography with an enan-
tioselective column. J High Resolut Chromatogr
21:39-46 (1998).
126. de Geus H-J, Wester PG, de Boer J, Brinkman
UATh. Unpublished data.
127. Boon JP, Helle M, Dekker M, Sleiderink HM, de
Leeuw JW, Klamer HJ, Govers B, Wester P, de
Boer J. In-vitro biotransformation of chlorinated
bornanes (toxaphene) in hepatic microsomes of
marine mammals and birds. Influence on bioac-
cumulation and mutagenicity. Organohalogen
Compounds 28:416-421 (1996).
128. Boon JP, Sleiderink HM, Helle MS, Dekker M,
van Schanke A, Roex E, Hillebrand MTJ, Klamer
HJ, Govers, B, Pastor D, Morse D, Wester P, de
Boer J. The use of microsomal in vitro assay to
study phase biotransformation of chlorobor-
nanes (Toxaphene®) in marine mammals and
birds. Possible consequences of biotransforma-
tion for bioaccumulation and genotoxicity.
Comp Biochem Physiol, Part C. 121:385-403
(1998).
129. BIum W, Aichholz R. Gas chromatographic
enantiomer separation on tert-butyidimethylsi-
lated f-cyclodextrin diluted in PS-086. A simple
method to prepare enantioselective glass capil-
lary columns. J High Resolut Chromatogr
13:515-518 (1990).
130. Vetter W, Klobes U, Luckas B, Hottinger G.
Enantioselective determination of toxaphene
and other organochlorines on tert.-butyl-
dimethylsilylated ,B-cyclodextrin. Organo-
halogen Compounds 33:63-67 (1997).
131. Schurig V. Enantiomer separation by gas chro-
matography om chiral stationary phases.
J Chromatogr A 666:111-129 (1994).
132. Buser HR, MOller MD. Isomeric and enantiomeric
composition of different commercial toxaphenes
and of chlorination products of (+)- and (-)-cam-
phenes. Am Chem Soc 42:393-400 (1994).
133. Vetter W, Klobes U, Hummert K, Luckas B. Gas
chromatographic separation of chiral
organochlorines on modified cyclodextrin
phases and results of marine biota samples.
J High Resolut Chromatogr 20:86-93 (1997).
134. Oehme M, MOller L, Karlsson H. High-resolu-
tion gas chromatographic test for the character-
isation of enantioselective separation of
orchanochlorine compounds-application to
tert-butyidimethylsilated ,B-cyclodextrin.
J Chromatogr A 775:276-285 (1997).
135. Vetter W, Klobes U, Luckas B, Hottinger G.
Enantioselective determination of persistent
toxaphene compounds on and alternatives to
tert-butyidimethylsilated 3-cyclodextrin.
Organohalogen Compounds 35:306-308 (1998).
136. Alder L, Palavinskas R, Andrews P. Enantio-
selective determination of toxaphene compo-
nents in fish, monkey adipose tissue from a
feeding study and human milk. Organohalogen
Compounds 28:410-415 (1996).
137. Vetter W, Klobes U, Luckas B, Hottinger G.
Enantiomeric resolution of persistent com-
pounds of technical toxaphene (CTTs) on
t-butyidimethylsilylated ,B-cyclodextrin phases.
Chromatographia 45:256-262 (1997).
138. Parlar H, Schulz-Jander D, Fingerling G, Koske
G, Angerhbfer D, Burhenne J. The role of biotic
and abiotic degradation processes during the
formation of typical toxaphene peak patterns in
aquatic biota. Organohalogen Compounds
35:221-224(1998).
139. Parlar H, Fingerling G, Angerhofer D, Christ G,
Coelhan M. Toxaphene residue composition as
an indicator of degradation pathways. In:
Molecular Markers in Environmental
Geochemistry (Eganhouse RP, ed), Washington:
American Chemical Society, 1997;346-364.
140. Buser HR, Muller MD. Isomeric and enan-
tiomeric composition of different commercial
toxaphenes and of chlorination products (+)-
and (-)-camphenes. J Agric Food Chem
42:393-400 (1994).
141. Voldner EC, Li YF. Global usage of selected per-
sistent organochlorines. Sci Total Environ
160/161:201-210 (1995).
142. Specht W, Stijve T, Thier H-P. Erfahrungen aus
einem Ringversuch zur Analyse von
Camphechlor-Ruckstanden in Fett. Lebens-
mittelchem Gerichtl Chem 41:125-126 (1987).
143. QUASIMEME Report on Round 10, DE-2
Exercise 333, Toxaphene Congeners in
Standard Solutions. Aberdeen, UK:FRS Marine
Laboratory, 1998.
144. Rice PR. Homologue concentrations of
chlorobornanes in selected samples from the
Bering/Chukchi Sea. Chemosphere 27:
1937-1 947 (1993).
145. Cleeman M, Paulsen GB, Pritzl G, Riget F,
Poulsen ME, de Boer J, Klungsoyr J. Organo-
chlorines in sediments and biota from
Greenland. Organohalogen Compounds 32:
268-271 (1997).
146. Muir DCG, Wageman R, Lockhart WL, Grift NP,
Billeck B, Metner D. Heavy Metal and Organic
Contaminants in Arctic Marine Fish.
Environmental Studies No. 42. Ottawa,
Canada:lndian and Northern Affairs Canada,
1 987;64.
147. Boer, J de, Geus H-J de, Brinkman UATh.
Multidimensional GC analysis of toxaphene.
Organohalogen Compounds 26:345-350 (1995).
148. Andersson 0, Linder CE, Olsson M, Reutergardh
L, Uvemo UB, Widequist U. Spatial differences
and temporal trends of organochlorine com-
pounds in biota from the northwestern hemi-
sphere. Arch Environ Contam Toxicol 17:
755-765(1988).
149. Jansson B, Vazz R, Blomkvist G, Jensen S,
Olsson M. Chlorinated terpenes and chlordane
components found in fish, guillemot and seal
from Swedish waters. Chemosphere 4:181-190
(1979).
150. Muir DCG, Ford CA, Stewart REA, Smith TG,
Addison RF, Zinck ME, Beland P.
Organochlorine contaminants in belugas,
Delphinapterus leucas, from Canadian waters.
Can Bull Fish Aquat Sci 224:165-190 (1990).
151. Wade TL, Chambers L, Gardinali PR, Sericano
JL, Jackson TJ. Toxaphene, PCB, DDT, and
chlordane analyses of beluga whale blubber.
Chemosphere 34:1351-1357 (1997).
152. Muir DCG, Wageman R, Grift NP, Norstrom RJ,
Simon M, Lien J. Organochlorine chemical and
heavy metal contaminants in white-beaked dol-
phins (Lagenorhynchus albirostris) and pilot
whales (Globicephala malaene) from the coast
of Newfoundland, Canada. Arch Environ Toxicol
Chem 17:613-629 (1988).
153. Taylor DL, Schliebe S, Metsker H. Conta-
minants in blubber, liver and kidney tissue of
Pacific walruses. Mar Poll Bull 20:465-468
(1989).
154. Muir DCG, Ford CA, Grift NP. PCBs and
organochlorine pesticides in Broughton Island
dietary samples. Final Report, November 1986.
Winnipeg, Canada:Department of Fisheries and
Oceans, 1986.
155. Muir DCG, Ford CA, Grift NP, Metner DA,
Lockhart WL. Geographic variation of chlori-
nated hydrocarbons in burbot (Lota Iota) from
142 Environmental Health Perspectives * Vol 107, Supplement I * February 1999
TOXAPHENE: OCCURRENCE, ANALYSIS, AND TOXICOLOGY
remote lakes and rivers in Canada. Arch Environ
Contam Toxicol 19:530-542 (1990).
156. Kidd KA, Eamer JE, Muir DCG. Spatial variabil-
ity of chlorinated bornanes (toxaphene) in
fishes from Yukon lakes. Chemosphere
27:1975-1986 (1993).
157. Calero S, Fomsgaard I, Lacayo ML, Martinez V,
Rugama R. Toxaphene and other organochlo-
rine pesticides in fish from Lake Xolotlan,
Nicaragua. Intern J Environ Anal Chem
53:297-305 (1993).
158. Gooch JW, Matsumura F. Evaluation of the toxic
components of toxaphene in Lake Michigan lake
trout. J Agric Food Chem 33:844-848 (1985).
159. Glassmeyer ST, De Vault, DS, Myers TR, Hites
RA. Toxaphene in Great Lakes fish: a temporal,
spatial, and trophic study. Environ Sci Technol
31:84-8 (1997).
160. Miskimmin BM, Muir DCG, Schindler DW, Stern
GA, Grift NP. Chlorobornanes in sediments and
fish 30 years after toxaphene treatment of lakes.
Environ Sci Technol 29:2490-2495 (1995).
161. Passinno DR, Smith SB. Acute bioassays and
hazard evaluation of representative contami-
nants detected in Great Lakes fish. Environ
Toxicol Chem 6:901-907 (1987).
162. Schmitt CJ, Zajicek JL, Ribick MA. National
pesticide monitoring program: residues of
chemicals in freshwater fish, 1980-1981. Arch
Environ Contam Toxicol 14:225-260 (1985).
163. Schmitt CJ, Ribick MA, Ludke, JL, May, TW.
Organochlorine residues in freshwater fish,
1976-1979: National Pesticide Monitoring
Program Resource Publ 152. Washington:U.S.
Fish and Wildlife Service, 1983;62
164. Muir DCG, Grift NP, Ford CA, Reiger A, Hendzel
M, Lockhart WL. Evidence for long range trans-
port of toxaphene to remote Arctic and subarctic
waters from monitoring of fish tissue. In: Long
Range Transport of Pesticides (Kurtz D, ed).
Chelsea, Ml:Lewis Publishers, 1990;329-346.
165. Stern GA, Muir DCG, Ford CA, Grift NP, Davailly
E, Bidleman TF, Walla MD. Isolation and
Identification of two major recalcitrant
toxaphene congeners in aquatic biota. Environ
Sci Technol 26:1838-1840 (1992).
166. Paasivirta J, Rantio T. Chloroterpenes and other
organochlorines in Baltic, Finnish and Arctic
wildlife. Chemosphere 22:47-55 (1991).
167. MOller R, Lach G, Parlar H. Comparative studies
on the presence of toxaphene residues.
Chemosphere 17:2289-2298 (1988).
168. Lach G, Parlar H. Quantification of toxaphene
residues in fish and fish products using a new
analytical standard. Chemosphere 21:29-34
(1990).
169. Oehme M, Svendsen JS, Kallenborn R,
Klungs0yr J. Characterization of a synthetic 4,5-
dichlorochlordene as internal standard for the
quantification of toxaphene and chlordane con-
geners in fish from the Arctic. Organohalogen
Compounds 26:333-338 (1995).
170. de Boer J, de Geus H-J, Brinkman UATh.
Multidimensional gas chromatographic analysis
of toxaphene-test of different column combi-
nations. Organohalogen Compounds 28:363-
368 (1996).
171. Fromberg A, Cederberg T, Hilbert G. Deter-
mination of toxaphene congeners in fish sam-
ples from Danish waters. Organohalogen
Compounds 35:259-262 (1998).
172. Lackey RW. Observations on the acute and
chronic toxicity of toxaphene in the dog. J Ind
Hyg Toxicol 31:117-120 (1949).
173. Stormont RT, Conley BE. Pharmacologic proper-
ties of toxaphene, a chlorinated hydrocarbon
insecticide. J Am Med Assoc 149:1135- (1952).
174. Henderson C, Pickering OH, Tarzwell CM.
Relative toxicity of ten chlorinated hydrocarbon
insecticides to four species of fish. Trans Am
Fish Soc 88:23 (1959).
175. Gaines T. Acute toxicity of pesticides. Toxicol
AppI. Pharmacol 14:515-534 (1969).
176. Pollock GA, Kilgore WW. Toxaphene. Residue
Rev 50:87-140 (1978).
177. Reuber MD. Carcinogenicity of toxaphene: a
review. J Toxicol Environ Health 5:729-748
(1979).
178. Lee G, Hughes R, Veith G. Evidence for partial
degradation of toxaphene in the aquatic environ-
ment. Water Air Soil Pollut 8:479-484 (1977).
179. Webb D. The effect of toxaphene pesticide on
benthic macro invertebrates. J Kan Entomol
Soc 53:731-744 (1980).
180. Delorme PD, Muir DCG, Lockhart WL, Mills KH,
Ward FJ. Depuration of toxaphene in lake trout
and white suckers in a natural ecosystem fol-
lowing a single l.P. dose. Chemosphere
27:1965-1973 (1993).
181. Mohammed A, Eklund A, Ostlund-Lindqvist A-M,
Slanina P. Tissue accumulation of lipoprotein
associated toxaphene in normo- and hypolipi-
demic mice. Arch Toxicol 64:38-42 (1990).
182. Coelhan M, Parlar H. Ecochemistry of
toxaphene. In: Ecotoxicology. Ecological
Fundamentals, Chemical Exposure, and
Biological Effects. Part 2: Chemicals in the
Environment (Schuurmann G, Markert B, eds).
New York/Germany:John Wiley & Sons/
Spectrum Akademischer Verlag, 1998;371-41 1.
183. Fingerling GM, Parlar H. Spectroscopic charac-
terization of 7b,8c,9c-trichlorocamphene-2-one
formed from toxaphene components in an
anaerobuc soil. J Agric Food Chem 45:
4116-4121 (1997).
184. Chandra J, Durairaj G. Effect of toxaphene toxi-
city on enzyme activity and residue levels in
vital organs of guinea pig. Indian J Med Res 98:
193-198(1993).
185. Keller AE. Acute toxicity of several pesticides,
organic compounds, and a wastewater effluent
to the freshwater mussel, Anodonta imbecilis,
Ceriodaphnia dubia, and Pimephales promelas.
Bull Environ Contam Toxicol 51:696-702 (1993).
186. Miskimmin BM, Schindler DW. Long-term
invertebrate community response to toxaphene
treatment in two lakes: 50-yr records recon-
structed from lake sediment. Can J Fish Aquat
Sci 51:923-932 (1994).
187. U.S. EPA. Criteria Document for Toxaphene. Fed
Reg 440/9-76-014 (1976).
188. Hudson RH, Tucker RK, Haegele MA. Effect of
age on sensitivity. Acute oral toxicity of 14 pes-
ticides to mallard ducks of several ages. Toxicol
AppI Pharmacol 11:556-561 (1984).
189. FAO/WHO. 1968 Evaluations of Some Pesticide
Residues in Food. Geneva:World Health
Organization, 1 969;267-283.
190. Johnson WW, Finley MT. Handbook of acute
toxicity of chemicals to fish and aquatic inverte-
brates. Resource Publ 137. Washington: U.S.
Fish and Wildlife Service, 1980.
191. U.S. EPA. Ambient Water Quality Criteria for
Toxaphene. EPA-440/5-80-076. Washington:
U.S. Environmental Protection Agency,
1980;113 pp.
192. Chernoff N, Setzer RW, Miller DB, Rosen MB,
Rogers JM. Effects of chemically-induced
maternal toxicity on prenatal development in
the rat. Teratology 42:651-658 (1990).
193. Trottman C, Desaiah D. Induction of rat hepatic
microsomal enzymes by toxaphene pretreat-
ment. J Environ Sci Health B15:121-134
(1980).
194. Chandra J, Durairaj G. Toxicity of toxaphene on
histopathology of vital organs in guinea pig,
Cavia procellus. J Environ Biol 13:315-322
(1992).
195. Kuntz DJ, Rao NGS, Berg IE, Khattree R,
Chatuvedu AK. Toxicity of mixtures of
parathion, toxaphene, and/or 2,4-D in mice.
J AppI Toxicol 10:257-266 (1990).
196. Chaturvedi AK. Toxicological evaluation of mix-
tures of ten widely used pesticides. J AppI
Toxicol 13:183-188 (1993).
197. Chandra J, Durairaj G. Toxicity of toxaphene on
the lipid profile in the vital organs of guinea
pig, Cavia procellus. J Environ Biol 16:75-81
(1995).
198. Rao KS, Prasada TC, Morrow W, Desaiah D.
Toxaphene inhibition of calmodulin-dependent
calcium ATPase activity in the rat brain synap-
tosomes. Fundam AppI Toxicol 6:648-653
(1986).
199. Chu I, Villeneuve DC, Sun CW, Secours V,
Procter B, Arnold E, Clegg D, Reynolds, L Valli
VE. Toxicity of toxaphene in the rat and beagle
dog. Fundam AppI Toxicol 7:7406-418 (1986).
200. Kavlock RJ, Chernoff N, Rogers E, Whitehouse
D, Carver B, Gray J. An analysis of fetotoxicity
using biochemical endpoints of organ differen-
tiation. Teratology 26:183-194 (1982).
201. Chernoff N, Carver BD. Fetal toxicity of
toxaphene in rats and mice. Bull Environ
Contam Toxicol 15:660-664 (1976).
202. Chaturvedi AK, Kuntz DJ, Rao NGS. Metabolic
aspects of the toxicology of mixtures of
parathion, toxaphene and/or 2,4-0 in mice.
J AppI Toxicol 11:245-251 (1991).
203. Keplinger ML, Deichmann WB, Sala F. Effects
of combinations of pesticides on reproduction
in mice. Ind Med Surg 37:525 (1968).
204. Kennedy GL Jr, Frawley JP, Calandra JC.
Multigeneration reproductive effects of three
pesticides in rats. Toxicol AppI Pharmacol
25:589-596(1973).
205. Chu I, Secours V, Villeneuve DC, Valli VE,
Nakamura A, Colin D, Clegg DJ, Arnold EP.
Reproduction study of toxaphene in the rat.
J Environ Sci Health B23:101-126 (1988).
206. Fahraeus-Van Ree GE, Payne JF. Effect of
toxaphene on reproduction of fish.
Chemosphere 34:855-867 (1997).
207. Safe S. Male sexual development in a sea of
estrogens. Lancet 342:125 (1993).
208. Wolf MS. Blood levels of organochlorine
residues and risk of breast cancer. J NatI
Cancer Inst 85:648-652 (1993).
209. Guillette LJ Jr, Gross TS, Gross DA, Rooney AA,
Percival HF. Gonadal steroidogenesis in vitro
from juvenile alligators obtained from contami-
nated or control lakes. Environ Health Perspect
103:31-36 (1995).
Environmental Health Perspectives * Vol 107, Supplement 1 * February 1999 143
de GEUS ET AL.
210. Vonier PM, Crain DA, McLachlan JA, Guillette
LJ Jr, Arnold SF. Interaction of environmental
chemicals with the estrogen and progesterone
receptors from the oviduct of the American alli-
gator. Environ Health Perspect 104:1318-1322
(1996).
211. Drenth H-J, Bouwman, CA, Seinen W, van den
Berg M Effects of some persistent halo-
genated environmental contaminants on aro-
matase (CYP19) activity in the human
choriocarcinoma cell line JEG-3. Toxicol AppI
Pharmacol 148:50-55(1998).
212. Ratnasabapathy R, Tom M, Post C Modulation
of the hepatic expression of the estrogen-regu-
lated mRNA stabilizing factor by estrogenic and
antiestrogenic nonsteroidal xenobiotics.
Biochem Pharmacol 53:1425-1434 (1997).
213. Lundholm CE. Influence of chlorinated hydrocar-
bons, Hg2+ and methyl-Hg+ on steroid hormone
receptors from eggshell gland mucosa of
domestic fowls and ducks. Arch Toxicol
65:220-227 (1991).
214. Soto AM, Chung KL, Sonnenschein C. The pes-
ticides endosulfan, toxaphene, and dieldrin
have estrogenic effects on human estrogen-
sensitive cells. Environ Health Perspect
102:380-383 (1994).
215. Soto AM, Sonnenschein C, Chung KL,
Fernandez MF, Olea N, Olea Serrano F. The
E-screen assay as a tool to identify estrogens:
an update on estrogenic environmental pollu-
tants. Environ Health Perspect 103(Suppl
7):113-122 (1995).
216. Bonefeld-J0rgensen EC, Autrup H, Hansen JC.
Effect of toxaphene on estrogen functions in
human breast cancer cells. Carcinogenesis
18:1651-1654 (1997).
217. Ramamoorthy K, Wang F, Chen I-C, Norris JD,
McDonnel DP, Leonard LS, Gaido KW,
Bocchinfuso WP, Korach KS, Safe S. Estrogenic
activity of a dieldrin/toxaphene mixture in the
mouse uterus, MCF-7 human breast cancer
cells, and yeast-based estrogen receptor
assays: no apparent synergism. Endocrinology
138:1520-1527 (1997).
218. NCI. Bioassay of Toxaphene for Possible
Carcinogenicity. Carcinogenesis Technical
Report Ser No. 37, DHEW Publ No. 79-837.
Bethesda. MD: National Cancer Institute, 1977.
219. Waritz RS, Steinberg M, Kinoshita FK, Kelly
CM, Richter WR. Thyroid function and thyroid
tumors in toxaphene-treated rats. Regul Toxicol
Pharmacol 24:184-192(1996).
220. Steinel HH, Arlauskas A, Baker RSU. SCE induc-
tion and cell-cycle delay by toxaphene. Mutat
Res 230:29-33 (1990).
221. Kang K-S, Wilson MR, Hayashi T, Chang C-C,
Trosko JE. Inhibition of gap junctional intercel-
lular communication in normal human breast
epithelial cells after treatment with pesticides,
PCBs, and PBBs, alone or in mixture. Environ
Health Perspect 104:192-201 (1996).
222. Moser GJ, Smart RC. Hepatic tumor-promoting
chlorinated hydrocarbons stimulate protein
kinase C activity. Carcinogenesis 10:851-856
(1989).
223. Hedli CC, Snyder R, Kinoshita FK, Steinberg M.
Investigation of hepatic cytochrome P-450
enzyme induction and DNA adduct formation in
male CD/1 mice following oral administration of
toxaphene. J AppI Toxicol 18:173-178 (1998).
224. Steinberg M, Kinoshita FK, Ballantyne, M.
Mutagenicity studies with toxaphene con-
geners. Organohalogen Compounds 35:
243-246(1998).
225. Schrader TJ, Boyes BG, Matula TI, Heroux-
Metcalf C, Langlois I, Downie RH. In vitro inves-
tigation of toxaphene genotoxicity in S.
typhimurium and Chinese hamster V79 lung
fibroblasts. Mutat Res 413:159-168(1998).
226. Sobti RC, Krisham A, Davies J. Cytokinetic and
cytogenetic effect of agricultural chemicals on
human lymphoid cells in vitro. 11: Organo-
chlorine pesticides. Arch Toxicol 52:221-231
(1983).
227. Ashendel CL, Staller JM, Boutwell RK. Protein
kinase activity associated with a phorbol ester
receptor purified from mouse brain. Cancer Res
43:4333-4337 (1983).
228. Brown lM, Blair A, Gibson R, Everett GD,
Cantor KP, Schuman LM, Burmeister LF, Lier
SF van, Dick F. Pesticide exposures and other
agricultural risk factors for leukemia among
men in Iowa and Minnesota. Cancer Res
50:6585-6591 (1990).
229. Cantor KP, Blair A, Everett G, Gibson R,
Burmeister LF, Brown LM, Schuman L, Dick FR.
Pesticides and other agricultural risk factors for
non-Hodgkinis lymphoma among men in Iowa
and Minnesota. Cancer Res 52:2447-2455
(1992).
230. IARC. Toxaphene (polychlorinated camphenes).
In: IARC Monographs on the Evaluation of the
Carcinogenic Risk of Chemicals to Humans. Vol
20: Some Halogenated Hydrocarbons. Lyon:
International Agency for Research on Cancer.
1979:327-348.
231. European Council Directive 76/895/EEC of 23
November 1976, relating to the fixing of maxi-
mum levels for pesticide residues in and on
fruit and vegetables. OJL 340, 9.12.1976, p 26.
232. German Maximum Residue Limit Ordinance of
24 June 1982, BGBI.I. p 745.
233. European Council Directive 93/58/EEC of 29
June 1993, amending Annex II to Directive
76/895/EEC relating to the fixing of maximum
levels for pesticide residues in and on fruit and
vegetables and the Annex to Directive
90/642/EEC relating to the fixing of maximum
levels for pesticide residues in and on certain
products of plant origin, including fruit and veg-
etables, and providing for the establishment of
a first list of maximum levels. OJL 211,
23.8.1993, p 6.
234. German Maximum Residue Limit Ordinance of 1
September 1994, BGBI.I. p 2299.
235. Alder L, Bache K, Beck H, Parlar H. Colla-
borative study on toxaphene indicator com-
pounds (chlorobornanes) in fish oil.
Organohalogen Compounds 26:369-374 (1995).
236. Second Amendment of the German Maximum
Residue Limit Ordinance of 7 March 1996,
BGBI.I. p 455.
237. Document No. 55/97 of the German Bundesrat
of 22.01.1997.
238. Third Amendment of the German Maximum
Residue Limit Ordinance of 26 September 1997,
BGBI.I. p 2366.
144 Environmental Health Perspectives * Vol 107, Supplement * February 1999
